<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJBIPHY</journal-id><journal-title-group><journal-title>Open Journal of Biophysics</journal-title></journal-title-group><issn pub-type="epub">2164-5388</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojbiphy.2022.121003</article-id><article-id pub-id-type="publisher-id">OJBIPHY-114597</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biomedical&amp;Life Sciences</subject><subject> Physics&amp;Mathematics</subject></subj-group></article-categories><title-group><article-title>
 
 
  Time-Fractal Modulation—Possible Modulation Effects in Human Therapy
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Andras</surname><given-names>Szasz</given-names></name><xref ref-type="aff" rid="aff1"><sub>1</sub></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib></contrib-group><aff id="aff1"><label>1</label><addr-line>Department of Biotechnics, Szent Istvan University, Budaors, Hungary</addr-line></aff><pub-date pub-type="epub"><day>13</day><month>12</month><year>2021</year></pub-date><volume>12</volume><issue>01</issue><fpage>38</fpage><lpage>87</lpage><history><date date-type="received"><day>12,</day>	<month>October</month>	<year>2021</year></date><date date-type="rev-recd"><day>11,</day>	<month>January</month>	<year>2022</year>	</date><date date-type="accepted"><day>14,</day>	<month>January</month>	<year>2022</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  The malignant processes deviate from the healthy homeostatic control, and various “tricks” enable malignant cells to avoid the healthy regulation. Consequently, the malignant structures miss the apoptosis and proliferate without restriction, and without the formation of communication networks in the newly formed cells. The modulation supports the homeostatic control to rearrange the health regulation processes in various ways. The modulation acts with stochastic processes, using stochastic resonances for molecular excitations, supporting the regulative enzymatic processes. The number of stochastic resonant frequencies is as many as the number of enzymatic reactions. The malignant cells differ structurally and dynamically in their connections and interactions from their healthy host tissues. The radiofrequency carrier is modulated with an appropriate time-fractal (1/f) noise to select the autonomic cancer-cells, destroy them, or force the precancerous, semi-individual cells to participate in the networking connections. The modulation in this way limits the cellular autonomy of malignant cells and boosts the healthy control. The resonant energy triggers apoptotic processes and helps immunogenic actions deliver extracellular genetic information for antigen-presentation. The modulation is applied in clinical practice. The therapy (modulated electro-hyperthermia, mEHT) is intensively used in oncology in complementary applications and for palliative stages, and occasionally even as a monotherapy.
 
</p></abstract><kwd-group><kwd>Pink-Noise</kwd><kwd> Homeostasis</kwd><kwd> Amplitude-Modulation</kwd><kwd> Cellular-Communication</kwd><kwd> Antigen-Presentation</kwd><kwd> Stochastic Resonances</kwd><kwd> Resonance Frequencies</kwd><kwd> Cellular Networking</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Healthy homeostasis controls the dynamic balance in the organism, ensuring the harmony of complex micro- and macro-interactions. Cancer destroys this harmony. The modulation goal is to find and force the malignant cells into apoptosis and to restore the healthy synchrony between cells and their communication.</p><p>The malignant processes are driven by the unicellular behavior and the individualism of the involved cells. The result is the breakdown of the integrity of the multicellular organization (which normally has a healthy networking structure). Cells with autonomy behavior have potential to better adapt to environmental changes. The transformation from the organized multicellular structure seen in healthy tissues to the structure seen in tumors is driven by the primitive transcriptional programs active in malignant cells [<xref ref-type="bibr" rid="scirp.114597-ref1">1</xref>]. The reorganization of the tumors structure supports the unicellular behavior and autonomy of the malignant cells, promoting the survival of the “colony” of malignant cells [<xref ref-type="bibr" rid="scirp.114597-ref2">2</xref>]. In an attempt to correct the abnormality, the healthy host initiates processes, such as angiogenesis, nerve healing, and numerous other supports, which instead provide essential conditions for the development of the malignancy. This regulation follows the general homeostatic control of the body. From the time that the malignancy appears in the tissue, cancer becomes a systemic disease. The dynamic control mechanisms of the healthy host are not able to repair the malignant lesion due to various reasons: genetic aberrations [<xref ref-type="bibr" rid="scirp.114597-ref3">3</xref>], mitochondrial dysfunction [<xref ref-type="bibr" rid="scirp.114597-ref4">4</xref>], and other intra- [<xref ref-type="bibr" rid="scirp.114597-ref5">5</xref>] and extracellular [<xref ref-type="bibr" rid="scirp.114597-ref6">6</xref>] hallmarks of cancer. Additional challenges which the host must face are the permanent uncontrolled stress on the system exerted by the malignancy [<xref ref-type="bibr" rid="scirp.114597-ref7">7</xref>], the recognition of the lesion as an unhealed wound [<xref ref-type="bibr" rid="scirp.114597-ref8">8</xref>], inflammation [<xref ref-type="bibr" rid="scirp.114597-ref9">9</xref>], and the blocking of apoptotic activity in malignant cells [<xref ref-type="bibr" rid="scirp.114597-ref10">10</xref>].</p><p>Cancer is an organizing (networking) disease, where the cells abandon the cooperative advantages [<xref ref-type="bibr" rid="scirp.114597-ref11">11</xref>]. The application of a tool that can help the homeostasis mechanisms to correct the cellular disorder of the malignant lesion and induce apoptosis, could allow for the cancerous cells, which are acting autonomously, to return to a healthy network by forcing cooperative harmony. Our objective is to show the possible effects of the modulated radiofrequency (RF) carrier, and its preclinical and clinical applications, in order to achieve this goal.</p></sec><sec id="s2"><title>2. Methods—The Modulationphenomena</title><p>The concept of modulation applied in physiology is centered on the stochastic dynamics (time-dependent events) in the biosystems. The chosen frequency spectrum is devoted to promoting healthy controls and intended to suppress cancerous processes. The carrier frequency is in the radiofrequency (RF) range which delivers an audio range (&lt;20 kHz) to the target. This method is well known and intensively applied by the various telecommunication networks (radio, TV, phone, GPS, etc.) to transfer information between the source and the distant targets.</p><p>The masking of the carrier can be achieved using different features of the RF wave, like its amplitude, frequency, or phase. The amplitude modulation was historically the first form of modulation, and it is the easiest to decode the delivered information (demodulation). The resulting shape of the signal follows the shape of modulation (<xref ref-type="fig" rid="fig1">Figure 1</xref>); mirroring the modulation signal at both the positive and negative side of the delivery. This amplitude modulation is very vulnerable to environmental noises and absorbents.</p><sec id="s2_1"><title>2.1. Why Modulation and not Direct Excitations?</title><p>The question naturally arises: while the advantages of frequency modulation include better stability over distance, less vulnerability to interferences, better selectivity, why then do we not propose applying directly the modulation frequencies in order to transmit information in biological systems without carrier frequency?</p><p>The challenge is to deliver the low frequency to the body and the selected places. The low frequencies are blocked by the heterogenic isolating (capacitive) factors in the application. The adipose tissue in the layer at the skin, the various membranes, and isolation compartments block the low-frequency current because their electric impedance inversely depends on the frequency. This resistivity becomes too high in low frequencies, and no deep targeting of structures is possible. In order to overcome the adipose layer, invasive application could be introduced, but other isolations remain.</p><p>The proper solution for the direct effect would be the invasive application of low-frequency, electrodes in the tumor itself, where the low-frequency effect of isolators is negligible. However, the inserted electrodes develop a layer on the surface of electrodes in the tumor, which produces a complex impedance effect (Warburg impedance, Z<sub>W</sub>) [<xref ref-type="bibr" rid="scirp.114597-ref12">12</xref>] and has an inverse-square-root dependence on the frequency (f). In a case of planar-electrode and sinusoidal supply, the Warburg impedance is [<xref ref-type="bibr" rid="scirp.114597-ref13">13</xref>]:</p><p>Z W ( f ) = A ( 1 − i ) f (1)</p><p>where A is a constant and i = − 1 . To avoid the Warburg impedance, a high</p><p>frequency is necessary. This noise could limit the accuracy of the measurements. However, in low frequencies, the large Warburg resistance also produces large electric noise because the electric noise of the resistance is proportional to the value of the actual resistivity [<xref ref-type="bibr" rid="scirp.114597-ref14">14</xref>].</p><p>The other advantage of the high frequency carrier is its impedance selection, which focuses the effects on the malignant cells, with the dispersion relation to attack the membrane rafts for exciting extrinsic signal pathways to apoptosis.</p></sec><sec id="s2_2"><title>2.2. The Modulation Process</title><p>The electromagnetic interactions with real biological systems are faced with a heterogeneous, non-linear, and complexly regulated target. The in vitro (cell lines), the ex-vivo (tissue samples), the in-vivo (animal experiments), and human applications differ from each other due to the heterogeneity and organization of the biological target. The active regulation processes in the targets, which are complex, could change the electrolytes in the tissue, varying the inhomogeneities, causing further complications in the evaluation of the interactions. The heterogeneity of the targets influences the results; however the structure and function of the cellular membranes have strong similarities, which allows for the use of some unified considerations.</p><p>The average isolation of the various membranes in the tissues is enormous ≈10<sup>13</sup> Ω/m [<xref ref-type="bibr" rid="scirp.114597-ref15">15</xref>]. It is so large that it can keep ≈ 70 mV at a distance of ≈7 nm, which is equivalent to ten million volts at a distance of one meter (≈10<sup>7</sup> V/m), and its capacity is ≈10<sup>−2</sup> (A∙s)/(V∙m<sup>2</sup>) = F/m<sup>2</sup>.</p><p>The cellular membrane, regulating the ionic transport of selected ionic species in and out of the cells. The idea corresponds to the triode or transistor when the current that flows through the device is non-linearly regulated with an intermediate action (net of base), which could amplify the time-dependent signal. The membrane is also a non-linear element [<xref ref-type="bibr" rid="scirp.114597-ref16">16</xref>]. Applying an RF signal on the membrane, it increases non-linearly <xref ref-type="fig" rid="fig2">Figure 2</xref>. The rectification is not ideal because a small amount of the opposite current also exists.</p><p>Measurement of the non-temperature dependent rectification (non-linearity) is not simple because it is not measurable through the living object when the integrity of the cells is intact. The current traveling through the cell meets twice with the transmitted signal, first from outside to inside the cell, and the second meeting is in the opposite direction. The two effects eliminate each other. The lipid bilayer, together with the ionic exchanges, completes the rectification phenomena [<xref ref-type="bibr" rid="scirp.114597-ref17">17</xref>] [<xref ref-type="bibr" rid="scirp.114597-ref18">18</xref>].</p><p>We had shown [<xref ref-type="bibr" rid="scirp.114597-ref19">19</xref>] the white noise excited linear system with infinite freedom, and cyclic symmetry emits pink noise. It works like a special filter creating 1/f noise from the non-correlated white noise spectrum, which was measured [<xref ref-type="bibr" rid="scirp.114597-ref20">20</xref>].</p><p>The Fourier transformation of x ( t ) pink noise is:</p><p>F ( f ) = A i 2 π | f | (2)</p><p>where A is the amplitude. The noise power spectrum:</p><p>S ( f ) = F * ( f ) F ( f ) = − i A 2 π | f | i A 2 π | f | = ( A 2 π ) 2 1 | f | (3)</p><p>where the star is a sign of conjugation. Let be the signal function v ( t ) of the carrier signal</p><p>v ( t ) = U 0 cos 2 π f v t (4)</p><p>where f v = 13.56   MHz is the frequency of the carrier, U 0 is its amplitude (voltage in electric signal). The f v carrier frequency is in the overlapping range of β/δ-dispersions. The Fourier transform of the y ( t ) = x ( t ) cos 2 π f v t modulated signal:</p><p>Y ( f ) = 1 2 F ( f − f v ) + 1 2 F ( f + f v ) (5)</p><p>The Fourier transform of the pink noise modulated carrier is:</p><p>Y ( f ) = 1 2 A U 0 i 2 π 1 | f − f v | + 1 2 A U 0 i 2 π 1 | f + f v | (6)</p><p>Physically, only positive frequencies can be realized, so the power spectrum is:</p><p>S ( f ) = − i 1 2 A U 0 2 π 1 | f − f v | i 1 2 A U 0 2 π 1 | f − f v | = ( A U 0 4 π ) 2 1 | f − f v | (7)</p><p>The power spectra of pink noise and pink noise embedded in the carrier are shown in <xref ref-type="fig" rid="fig3">Figure 3</xref>. The noise power spectrum shifts to the ω 0 = 2 π f 0 circular frequency of the periodic carrier.</p><sec id="s2_2_1"><title>2.2.1. Amplitude Modulation-Stochastic Resonance</title><p>Many chemical reactions have a coordinated subsequent chain, having a series of reactions in a definite order. This set is called the Markov process, a chain-like stochastic reaction-line. When the sequence of the realized states is such, each step depends solely on the state realized in the previous event <xref ref-type="fig" rid="fig4">Figure 4</xref>.</p><p>The biological processes have well-organized and controlled Markovian chain reactions, avoiding the sudden single-step liberation of energy during the catabolism. The series of effects in the time dynamics are Markovian. A two-state Markov process in which we assume that the coefficients can be influenced by an external electric field are described as follows:</p><p>d p 1 d t = − α p 1 + β p 2 d p 2 d t = α p 1 − β p 2 , p 1 + p 2 = 1 (8)</p><p>where p i ( i = 1 , 2 ) is the probability of the actual state, and α and β depend on the external electric field. This is the master equation of a Brownian particle bouncing back and forth in a potential well with two minima, excited by a force</p><p>of an external periodic field.</p><p>The cell works appropriately as long as the catalyst enzymes are not poisoned and, obviously, as long as the catalyst has something to catalyze. More specifically, although coenzymes provide a high degree of enzyme selectivity, there may be substances which have suppressor functions (enzyme poisons) that react in an opposite enzymatic way, or the coenzymes act to support the enzyme reaction (promoter function). On the other hand, when the cell actually does not have molecules to catalyze, the chemical reactions are terminated. We assume that the two states of the enzyme, A, and B, are stable but interchanging. The two states are the result of chemical reactions, with α forward, and β backward reaction rate:</p><p>A ⇄ β α B (9)</p><p>The concentration of the enzyme by [A] and [B] in confirmation states A and B. Then,</p><p>the kinetic equations of the reaction in (9):</p><p>d [ A ] d t = − α [ A ] + β [ B ] d [ B ] d t = α [ A ] − β [ B ] (10)</p><p>Enter the quantities in (10): [ T ] = [ A ] + [ B ] , p 1 = [ A ] [ T ] , p 2 = [ B ] [ T ] , the equation has the same form as the master Equation (8).</p><p>The study of a voltage-gated ion channel defines A ≡ O , and B ≡ C , where O is the open state and C is the closed state. In this way, the kinetic equation of the ion channel is again the master Equation (8).</p><p>To determine the mathematical form of transient probabilities, we examine the stationary state of (8). Then, d p i d t = 0 so</p><p>p 1 p 2 = β α (11)</p><p>The energy of the two states &#177;ΔE deviates from the reference level and assumes a Boltzmann distribution:</p><p>p 1 p 2 = β α = e − E 0 + Δ E k T e − E 0 − Δ E k T (12)</p><p>We obtain the Arrhenius law for reaction rates from (12):</p><p>α = C e − E 0 − Δ E k T ,     β = C e − E 0 + Δ E k T (13)</p><p>With this, from (8), we get a differential equation; e.g., for p 1</p><p>2 τ d p 1 d t = − ( e Δ E k T + e − Δ E k T ) p 1 + e − Δ E k T , 2 τ = ( C e − E 0 k T ) − 1 (14)</p><p>Apply Taylor series and stop at the first term, then</p><p>d p 1 d t = − 1 τ p 1 + 1 2 τ − 1 2 τ Δ E k T , 2 τ = ( C e − E 0 k T ) − 1 (15)</p><p>When the field strength is a harmonic function of time, the energy depends on it linearly:</p><p>Δ E = a sin ω t (16)</p><p>From (15) and (16), we get</p><p>d p 1 d t = − 1 τ p 1 + 1 2 τ − 1 2 τ a k T sin ω t (17)</p><p>To find the form of the excitation, the stationary solution of the following inhomogeneous differential equation has to be determined:</p><p>d p d t + 1 τ p = − 1 2 τ a k T sin ω t (18)</p><p>which is</p><p>p ^ ( k T ) = a 2 k T 1 τ 2 ω 2 + 1 = a 2 k T 1 1 + ( e E 0 k T 2 C ω ) 2 (19)</p><p>The solution shows that the probability associated with such an excitation varies according to a harmonic function with time, regarding the noise intensity of the thermal background kT. It follows a sharp maximum at a given f frequency as a function of kT noise intensity <xref ref-type="fig" rid="fig5">Figure 5</xref>.</p><p>Formulate this result oppositely: this also means that there is a frequency where the amplitude is maximum for a given noise level. The stochastic resonance rules also such microscopic molecular structural changes like the protein folding phenomenon [<xref ref-type="bibr" rid="scirp.114597-ref21">21</xref>].</p></sec><sec id="s2_2_2"><title>2.2.2. Demodulation Stochastic Resonance</title><p>The modulated carrier signal targets the selected malignant cells, and the cells rectify (demodulate) the received signal. The demodulation is basically a rectification process, which uses stochastic resonance [<xref ref-type="bibr" rid="scirp.114597-ref22">22</xref>]. The decomposition of (14):</p><p>2 τ d p 1 d t = − ( 2 + ( Δ E k T ) 2 ) p 1 + 1 − Δ E k T + 1 2 ( Δ E k T ) 2 , 2 τ = ( C e − E 0 k T ) − 1 (20)</p><p>Assume the field strength of the modulated signal is a harmonic function of time and let the energy depend linearly on it</p><p>Δ E = a ( 1 + m cos Ω t ) sin ω t (21)</p><p>where m &lt; 1 , the modulation depth Ω is the modulator and the ω carrier frequency.</p><p>Substituting this into our previous equation, we get that</p><p>2 τ d p 1 d t = − ( 2 + ( a k T ) 2 ( 1 + m cos Ω t ) 2 sin 2 ω t ) p 1                         + 1 − a k T ( 1 + m cos Ω t ) sin ω t + 1 2 ( a k T ) 2 ( 1 + m cos Ω t ) 2 sin 2 ω t , 2 τ = ( C e − E 0 k T ) − 1 (22)</p><p>As a function of probability over time, there is a slow change and a rapid fluctuation. The first is from the modulation, and the second is from the carrier.</p><p>We are only interested in slow change now. To filter this out of the above equation, we average it over the time of the carrier period. In this case, the slow signal can be considered constant for the time functions, and the time average can be replaced by the fast one.</p><p>Under this rule, the slow change is</p><p>2 τ d p 1 d t = − ( 2 + ( a 2 k T ) 2 ( 1 + m cos Ω t ) 2 ) p 1                         + 1 + 1 2 ( a 2 k T ) 2 ( 1 + m cos Ω t ) 2 , 2 τ = ( C e − E 0 k T ) − 1 (23)</p><p>equation describes.</p><p>Suppose the modulation depth is small. Then our above equation can be further simplified:</p><p>2 τ d p 1 d t = − ( 2 + ( a 2 k T ) 2 ( 1 + 2 m cos Ω t ) ) p 1 + 1       + 1 2 ( a 2 k T ) 2 ( 1 + 2 m cos Ω t ) (24)</p><p>This is now a linear differential equation with variable coefficients.</p><p>Although there is a general solution to this, we are not going anywhere with it, so we will apply the method of successive approximation to the solution.</p><p>Since we are looking for resonance, we only study the effect of the harmonic excitation function:</p><p>2 τ d p d t + [ 2 + ( a 2 k T ) 2 + ( a k T ) 2 m cos Ω t ] p = ( a 2 k T ) 2 m cos Ω t (25)</p><p>Introduce the</p><p>F ( p ) : = 2 τ d p d t + [ 2 + ( a 2 k T ) 2 ] p , f ( p ) : = p ( a k T ) 2 m cos Ω t (26)</p><p>expressions that are continuous functions of p.</p><p>Steps of successive approximation:</p><p>F ( p 1 ) = ( a 2 k T ) 2 m cos Ω t , F ( p 2 ) = f ( p 1 ) , F ( p i ) = f ( p i − 1 ) (27)</p><p>Now it’s true that</p><p>F ( p 1 ) + F ( p 2 ) + ⋯ + F ( p i ) = F ( p 1 + p 2 + ⋯ + p i ) = ( a 2 k T ) 2 m cos Ω t + f ( p 1 ) + f ( p 2 ) + ⋯ + f ( p i − 1 ) = ( a 2 k T ) 2 m cos Ω t + f ( p 1 + p 2 + ⋯ + p i − 1 ) (28)</p><p>If the procedure is convergent, then if i → ∞ , the line proceeds to the solution, and due to the required continuity the above expression reduces to the simple equation:</p><p>F ( p ) = ( a 2 k T ) 2 m cos Ω t + f ( p ) (29)</p><p>Now let’s look at the first approximation! This gives a solution of a smooth diff equation.</p><p>2 τ d p 1 d t + [ 2 + ( a 2 k T ) 2 ] p 1 = ( a m 2 k T ) 2 cos Ω t (30)</p><p>The amplitude of the variable probability according to the harmonic function with modulating frequency can now be determined as follows:</p><p>p ^ 1 ( R T ) = ( a m 2 k T ) 2 1 4 τ 2 Ω 2 + [ 2 + ( a 2 k T ) 2 ] 2 = ( a m 2 k T ) 2 1 [ 2 + ( a 2 k T ) 2 ] 2 + ( e E 0 k T C Ω ) 2 (31)</p><p>It is a resonance again <xref ref-type="fig" rid="fig6">Figure 6</xref>.</p></sec></sec><sec id="s2_3"><title>2.3. Effects of Modulation in Human Therapy</title><p>The expected actions mark out the following basic goals:</p><p>1) Supports the healthy network over the unhealthy network.</p><p>2) Selectively targets the cancer.</p><p>3) Supports the immune system, boosts the homeostatic harmony and chains of reactions.</p><p>4) Excites the selected molecules in selected cells for special molecular and immunogenic changes.</p><p>Due to the complex interconnection of the living objects, these effects are overlapping and are supporting each other.</p><p>In the following sections, we focus on emphasizing the features of modulation for fighting against cancer, which is a disease of the dynamic equilibrium breaking the multicellular cooperative network into unicellular individualism of the autonomic “selfish” cells. The task is twofold:</p><p>1) find and destroy the malignant cells. The intention is to act with the local treatment systemically, extend the task to the entire body;</p><p>2) force cellular homeostasis harmony with a homeostatic synchronization signal.</p><sec id="s2_3_1"><title>2.3.1. Boost the Healthy Network</title><p>The role of each cell supports each other in the cellular network in a tissue, there must be an interaction between them to realize this. One such possibility is the cyclic interaction in which the thermal noise is eliminated and instead a noiseless mode of information exchange appears [<xref ref-type="bibr" rid="scirp.114597-ref23">23</xref>]. When an abnormality occurs in cellular functions the cyclic symmetry locally brakes. The networked communication between the cells develops disturbances and that became noisy resulting in a break in the communication between cells. The thermal noise at least locally overtakes the healthy harmony. This is a change in the physiological information and is accompanied by broken psychological harmony causing a malaise state.</p><p>The social inclination is encoded by evolution into DNA. It is capable of creating a form of movement in which only noiseless modes are realized. As a result, two effects are realized, the noiseless communication, and harmony of physiochemical processes with stress and hormone dependent psychochemical ones. This later is a brain-controlled systemic process, fixing the well-being.</p><p>1) One of the crucial steps to re-establish the cyclic symmetry is the synchrony between the cellular activities. The self-synchronization of the chemical processes was observed in the famous Belousov-Zhabotinsky (BZ) reaction [<xref ref-type="bibr" rid="scirp.114597-ref24">24</xref>]. The BZ reactions are far from thermal equilibrium and evolve chaotic features [<xref ref-type="bibr" rid="scirp.114597-ref25">25</xref>], providing a chemical model of self-organized, synchronized but non-equilibrium biological processes and noise-assisted ordering [<xref ref-type="bibr" rid="scirp.114597-ref26">26</xref>]. The self-synchronization of chemical oscillators is also a known phenomenon [<xref ref-type="bibr" rid="scirp.114597-ref27">27</xref>]. An interesting example of neurological harmony is the synchrony promoted by the music affecting neuronal interactions merging the γ, β, and θ EEG signals as electrical synchrony [<xref ref-type="bibr" rid="scirp.114597-ref28">28</xref>]. Recognition of the harmony in 1/f noise fluctuations in music [<xref ref-type="bibr" rid="scirp.114597-ref29">29</xref>], connected to the short-range autocorrelation of rhythms [<xref ref-type="bibr" rid="scirp.114597-ref30">30</xref>]. The synchrony between the living components and the connected, synchronized coupling in living organisms is essential, and the resonance is a highly effective way to achieve it [<xref ref-type="bibr" rid="scirp.114597-ref31">31</xref>]. When the living system functions normally, there are noiseless modes of internal communications. The environment is however noisy, and the living information exchange faces this challenge. This means that the system must work among various external noises and must be perfectly controlled, even in changing thermal white-noise resulting from temperature in a physiologic interval. This ensures the dynamic equilibrium, the homeostasis.</p><p>2) The physiological state includes a dynamic chemically driven psychological state in the living organism corresponding to well-being. The relationship between physiological and conscious processes has puzzled many researchers, including Schr&#246;dinger [<xref ref-type="bibr" rid="scirp.114597-ref32">32</xref>]. Apparently, the physicochemical processes that take place in each cell are the same, but the healthy cells are under the control of others in the network (“social” signaling [<xref ref-type="bibr" rid="scirp.114597-ref33">33</xref>] ) which is a collective action. Social information should spread within the body without loss of information. This accompanied psychological process corrects the well-being. The realization of stochastic resonance indicates that the states of well-being are discrete. Their change is like a “resonance”. Based on a finite number of distinguishable states of well-being, it is also likely that the number of modes of communication or modes of disintegration is finite.</p><p>The stored information passed down to the new cells through the individual DNA molecules regulates the organ’s function, but cannot be designated as controllers of the described self-organized communication. Despite their ability to store all the information about the body in the nucleic DNA, the cells, due to the organ collectivity, use only those pieces of information appropriate to their tasks in the organ. The intranuclear DNA is a blueprint for the production of the new cell. This condition provides amazingly high safety in the functioning of the organ. The “social” communication allows the organ to function even when a part of it is damaged. This is essentially Neumann’s concept of realizing a high-reliability system from low-reliability ones [<xref ref-type="bibr" rid="scirp.114597-ref34">34</xref>].</p><p>As the network becomes extensive, the communication signal goes over greater distances in an intensively noisy environment, so more and more information is being lost by distance. In the end, the cell cannot recover the received information. Beyond a limit, noise wins, no matter how good the noise-suppressing ability of the communication network of cells is. It can be assumed that the disintegration of the information network is a process similar to the phenomenon of stochastic resonance, i.e., the addition of a small amount of noise leads to the emergence of novel, primarily chaotic behavior. It is reasonable to assume that with stochastic resonance, that cell that lost its communication commits suicide, i.e., ends up with apoptosis.</p><p>The collective excitations comprise the non-local waves and activate the energy flow in the homeostatic networks. These excitations are mainly in the low-frequency range, and the expected frequency spectrum follows the natural 1/f fluctuations [<xref ref-type="bibr" rid="scirp.114597-ref35">35</xref>].</p><p>The self-similar self-organizing process is collective [<xref ref-type="bibr" rid="scirp.114597-ref36">36</xref>] and relates to the scale-independent phenomena [<xref ref-type="bibr" rid="scirp.114597-ref37">37</xref>]. Terminals of a circulatory system to supply an organ adjacent to the cells are equivalent and supply the cells with the same functions equally. The collectivity subordinates the individual needs to the groups and optimizes the energy distribution for the best survival with the lowest energy consumption. This energy-share works like some kind of democracy [<xref ref-type="bibr" rid="scirp.114597-ref38">38</xref>].</p><p>One of the fundamental ordering principles for healthy living subjects is a characteristic “democratic” energy supply in their organisms for optimal energy consumption. The “democratic” idea is more general than just the energy supply. It characterizes the information distribution, as well [<xref ref-type="bibr" rid="scirp.114597-ref39">39</xref>].</p><p>This “democracy” is regulated by general biophysical rules, governed by the competition for resources in micro- and macro-phenomena, having intensive interaction with their environment. The goal of the multicellular living object is forming cooperation, optimizing the energy intake. Due to its energetically openness, the individual living object needs internal cooperative distribution of the incoming energy. The survival of its parts determines the overall survival of the object, so the optimization of energy distribution is crucial.</p><p>In healthy multicellular systems, numerous mitochondria help the individual cellular functions. Even the otherwise similar cells may vary substantially in their mitochondrial content, together with their size and membrane potential [<xref ref-type="bibr" rid="scirp.114597-ref40">40</xref>]. The variation arises from uneven partitioning at cell division, producing extrinsic differences in energy demand and supplied cellular processes [<xref ref-type="bibr" rid="scirp.114597-ref41">41</xref>]. The cells which have considerable energy demand for their normal function have a higher number of mitochondria. For example, the mitochondria fill up ~20% of the entire cell volume of human liver cells, and they work cooperatively to serve the extreme hepatocellular ATP demand [<xref ref-type="bibr" rid="scirp.114597-ref42">42</xref>]. The uneven mitochondrial density in different kinds of cells shows the energy distribution problem between the cells. The cells use different energies depending on their function, so the “democratic” distribution of energy between all cells equally obviously does not work. However, another kind of “democracy” works: the cells have well-controlled and balanced energy parts depending on their function in the collective. The structure of the entire system optimizes the energy distribution. The energy balance realizes a variation of the transport network supplying the variations of the demand. This directly requires that the fractal structure of transport is not unified as structure in the system, but of the formed or homeostatic demands.</p><p>The balancing of autocracy and democracy characterizes the evolution when the “selfish gene” [<xref ref-type="bibr" rid="scirp.114597-ref43">43</xref>] attempting to dominate all processes, but the environment-dependent self-organization requests democratic decisions; otherwise, the process blocks the system’s complexity. The game with two actions to cooperate or defect well approaches the biological interactions [<xref ref-type="bibr" rid="scirp.114597-ref44">44</xref>]. The relevance of the strategies of such alternating games is sometimes more appropriate than synchronous games [<xref ref-type="bibr" rid="scirp.114597-ref45">45</xref>].</p><p>Moreover, the complex homeostatic control shows the balancing of feedback mechanisms. The negative-feedback interaction tunes to keep the actual state as close to the accurate value, determined by the self-organizing system. Nevertheless, the system is energetically open, which is the mandatory condition for life, so the positive feedback mechanisms force some reactions, determining the metabolic processes in both directions (catabolism and anabolism). This obligatory constraint derives a certainly autocratic line when the probability of reactions drives the defined direction so the processes. Such necessary autocratic strategies can be beneficial for exerting control over asymmetric interactions [<xref ref-type="bibr" rid="scirp.114597-ref46">46</xref>]. The regulatory networks have many similarities, from microbes to humans [<xref ref-type="bibr" rid="scirp.114597-ref47">47</xref>]. The regulation of collaboration and cooperation massively boosts the democratic character with overall genomic complexity. The regulatory effects in complexity have a propensity to a partnership supporting the democratic structure, whereas others regulate primarily in isolation, in a more autocratic fashion [<xref ref-type="bibr" rid="scirp.114597-ref48">48</xref>]. The degree of collaboration forming autocratic, in opposition to democratic, behavior is a specific character of the complexity in the open living systems.</p><p>Considering the complexity, the compulsory synchronization attempt by external modulated electric forces looks like a promising strategy in the cases when the collective harmony (the homeostatic regulation) is lost.</p></sec><sec id="s2_3_2"><title>2.3.2. Selecting Mechanisms</title><p>The biochemically masked, hidden tumor cells show biophysical peculiarities. This biophysical evidence is not enough to turn the immune attention on the tumors but could select them and force the selected cells to show their factual genetic errors.</p><p>The first recognizable feature is their enlarged metabolic rate. Due to the intensive proliferation, the energy demand of these cells exceeds the rate of their healthy hosts. The ion transports in their environment increase the conductivity as a result of the higher ionic concentrations. So the adequately chosen RF current has a higher current density in the tumor region, where the electric conductivity is higher than in the healthy host. The high current density in tumor allows for the use of the RF energy to act selectively on cancer and host tissues.</p><p>The impedance measurements on Erlich solid tumors [<xref ref-type="bibr" rid="scirp.114597-ref49">49</xref>] identifies the particular fractal structure of malignancy. As the above discussions explained, the malignant specialties dynamically lower the conductivity of the tumor and the definite percolative self-similarity, with a lower impedance than the healthy host [<xref ref-type="bibr" rid="scirp.114597-ref50">50</xref>].</p><p>The biophysical selectivity has another distinguishing phenomenon due to the cellular autonomy of cancer cells [<xref ref-type="bibr" rid="scirp.114597-ref51">51</xref>] [<xref ref-type="bibr" rid="scirp.114597-ref52">52</xref>]. The intensive proliferation forms the autonomic feature of the cancer cell. The cytoskeleton of the cells frequently collapses and re-polymerises due to frequent fission. The intercellular connection is connected to the mitotic spindle [<xref ref-type="bibr" rid="scirp.114597-ref53">53</xref>], so the dividing cell breaks its connections with the neighbors during the division process [<xref ref-type="bibr" rid="scirp.114597-ref54">54</xref>]. Autonomy is a perfect concept as a hallmark of malignant cells. However, this hallmark formulates a more uncomplicated situation than the complex process works in reality [<xref ref-type="bibr" rid="scirp.114597-ref5">5</xref>].</p><p>Nevertheless, one factor of this phenomenon offers a selection possibility, the weakening or complete loss of the networking connections of these cells to their neighbors. The loss of the cadherin intercellular links promotes tumor growth [<xref ref-type="bibr" rid="scirp.114597-ref55">55</xref>], and allows increased motility of the cells [<xref ref-type="bibr" rid="scirp.114597-ref56">56</xref>], and changes the microenvironment around it. The rearrangement of the structure in this region, due to the autonomic behavior, changes the dielectric permittivity, distinguishing these cells’ changed impedance from the healthy cells [<xref ref-type="bibr" rid="scirp.114597-ref57">57</xref>]. The modified environment makes the cell recognizable by the RF-current, which flows through the selected tumor.</p><p>The third selective factor uses the modified structure of the tissue’s pattern, which is a usual experience of the pathologists to identify the stage and prognosis of the malignancy. The pattern changes the impedance for the RF-current, and also its reaction to the modulation of the carrier frequency fundamentally differs when it forces healthy harmony. The well-chosen modulation delivers such a time pattern, which corresponds with the homeostatic dynamism, and is synchronized with some basic phenomena. But, the cancer is out from this harmony, and the modulation drastically differs from their dynamic properties. There is a simple analogy to represent this process with the pushing of the swing in the playground. When the push is in harmony with the swing’s pendulum, it keeps moving with a small amount of energy; however, when the energizing push is out of harmony, considerable energy is lost, and the swing loses its kinetic energy. The applied modulation (synchronization) strategy has to be harmonized with the homeostatic regulation of individual systems.</p></sec><sec id="s2_3_3"><title>2.3.3. Control the Autonomy of Cells</title><p>Distinguishing the networked, and individual cells was studied in detail by the Nobel Laureate A. Szent-Gyorgyi. He applied an etiological approach: how does the cellular collectivity disappear [<xref ref-type="bibr" rid="scirp.114597-ref53">53</xref>] ? He focused on the pyruvate metabolic pathways for ATP production. He termed the cell which uses the pyruvate dominantly on fermentative way α-state, which characterized the start of cellular evolution when no free oxygen was available [<xref ref-type="bibr" rid="scirp.114597-ref58">58</xref>]. This developmental period was unicellular, with the simple operation of life and replicated as much as possible. These individual cells compete for their demands; acting autonomously, without any cooperative communication. The appearance of free oxygen changed the game of life and made it possible to develop cooperative multicellular units, called β-state. The energy production was taken by a “power plant” in the cell, the mitochondria. Intensive diversity of life was available. The cooperatively connected cells in β-state share the tasks of living processes, to optimize the efficacy of the life.</p><p>The evolution on the cellular level is explained by an interplay of α- and β-stages [<xref ref-type="bibr" rid="scirp.114597-ref53">53</xref>]. The regular cooperative system in β-stages interrupted by the reproduction process when the cell breaks its collective functions, became an individual (α-state) to produce its daughter cells, and after this, integrates with the new cells into the system forming β-states. So the α-state locally terminates the multicellular cooperative complexity. The cooperative living complexity easily and naturally transforms into a basic, dividing α-state. When the network is broken, the system becomes unstable, parallel with stable, independent cells in α-state form [<xref ref-type="bibr" rid="scirp.114597-ref59">59</xref>]. The cells in β-state are cooperative, energizing themselves with oxidative metabolism provided by their mitochondria. Their division should be strictly controlled by the networking cells and dynamic processes.</p><p>Normal cellular division transforms locally the β-state to α-state, which is a normal process in the multicellular system, although it hurts the systemic collectivity in that local volume. Irregularity happens when the dividing cell remains in α-state, because the individual local conditions prefer autonomy, which ensures a high amount of energy intake to the cell. The long-time optimal collective demand overcame the individual interest of the cell. This state develops cancer which is regarded as “dismantling of multicellularity” [<xref ref-type="bibr" rid="scirp.114597-ref60">60</xref>].</p><p>The embryonic cellular organization could be a model of how the cancerous cluster can be stabilized. The “renegade” single-cell [<xref ref-type="bibr" rid="scirp.114597-ref61">61</xref>] is the cell born with a genetic deviation allowing its further development to remain individual. This behavior could be the starting step of forming a malignancy. The driving principle is the mass-dependent allometry of tumor mass [<xref ref-type="bibr" rid="scirp.114597-ref62">62</xref>]. The observed scaling follows from the linear dependence of the relative changes of the parameters. In general, when c is a constant and a and b are the parameters, then:</p><p>d b b = c d a a (32)</p><p>The (32) scaling is observed in the allometric comparison of the various living masses and their metabolic rates [<xref ref-type="bibr" rid="scirp.114597-ref63">63</xref>], where the basal metabolic rate of tumor ( B c ) is proportional with 3/4<sup>th</sup> of the M mass of the tumor: B c ∝ M 3 / 4 , so the metabolic rate for unit volume:</p><p>B c M ∝ M − 1 / 4 (33)</p><p>On the other the lifespan T of the tumor also has approximately the same dependence from the mass [<xref ref-type="bibr" rid="scirp.114597-ref64">64</xref>]:</p><p>T ∝ M 1 / 4 (34)</p><p>Note that the universality of the values of exponents has intensive debates [<xref ref-type="bibr" rid="scirp.114597-ref65">65</xref>] [<xref ref-type="bibr" rid="scirp.114597-ref66">66</xref>] [<xref ref-type="bibr" rid="scirp.114597-ref67">67</xref>]. However, there is a consensus that the exponent α &lt; 1 . This also means that as the final mass increases, the metabolism of unit mass decreases, and at the same time, the mortality rate of the cells lowers. Compare the approximated lifespan of tumor ( T tumor ) and the healthy part of the body ( T healthy ), using the estimate in (34):</p><p>T tumor T healthy = ( M tumor M healthy ) α (35)</p><p>where α &lt; 1 (most frequently it is α ≅ 1 / 4 ) and M tumor and M healthy are the mass of tumor and the healthy body part which is affected by the tumor, respectively. It is obvious, that M tumor &lt; M healthy , so from (35)</p><p>T tumor T healthy &lt; 1 (36)</p><p>We assume that the regulators of complete homeostatic control (proliferation, morphogenesis, physiology, immune system, etc.) have an intervention time varying according to (34). As a result of (36), the regulation time of the tumor is shorter than the healthy reaction. Hence, the tumor reacts quicker than the healthy regulation system, so its growth escapes from the standard supervision. The consequence of this is that the regulators in the body are unable to control an activated cancerous cellular cluster.</p><p>Since the embryonic cell must be connected to the food network of the adult body, it must develop and increase in its direction by a known mechanism of vascularization. But in the adult body, it is also slow as it has adapted to the adult body. The process goes through the genetic instability of cancer [<xref ref-type="bibr" rid="scirp.114597-ref68">68</xref>] [<xref ref-type="bibr" rid="scirp.114597-ref69">69</xref>]. The p53 gene is the guardian of the genome. It ensures that the genome is stable for the long term. This requires that the p53 gene maintains the appropriate level of p53 protein in the intracellular space. A change in environmental conditions is a stress effect. When it persists for a long time, permanent stress is created. Inflammation and hypoxia are lasting stress effects, reducing the level of p53 protein in the cell. The weakened stability of the genome is observed by inflammation [<xref ref-type="bibr" rid="scirp.114597-ref70">70</xref>], and hypoxia [<xref ref-type="bibr" rid="scirp.114597-ref71">71</xref>], and so increased likelihood of mutations appears. The bystander effect produces precancerous cells in the neighborhood of the cells with intensive permanent stress and the consequent genetic instability [<xref ref-type="bibr" rid="scirp.114597-ref72">72</xref>]. The control needs re-regulation of the tumorous area locally and also systemically [<xref ref-type="bibr" rid="scirp.114597-ref73">73</xref>].</p></sec><sec id="s2_3_4"><title>2.3.4. Excite Selected Molecules</title><p>The special autonomy and high metabolic activity of the malignant cells allow recognition, and the selection and attack of them. The energy provided with the carefully chosen RF current targets the selected cells and excites a few chemical changes in the selected malignant cells.</p><p>Electromagnetic selection of the malignant cells guides the energy delivery. The living targets are inherently heterogenic in thermal and electric properties, so the structural selection at the cellular level needs additional selection to target the chosen heterogeneity of the malignant cells. For this, we have to choose the carrier frequency, acting on different parts of the tissue structure. The applied RF current triggers various processes, which are often grouped in dispersion regions by frequency, defined by the main character of the bio-electromagnetic exchanges.</p><p>The β-dispersion (~1 kHz - ~100 MHz broad spectrum) is linked to the cellular structure of biological materials [<xref ref-type="bibr" rid="scirp.114597-ref74">74</xref>]. It occurs at the interface of membrane-electrolyte structures, using Maxwell-Wagner relaxation [<xref ref-type="bibr" rid="scirp.114597-ref75">75</xref>]. The effect is an interfacial polarization of the cell membranes [<xref ref-type="bibr" rid="scirp.114597-ref76">76</xref>], resulting in the charge distribution at the cellular of interfacial boundaries [<xref ref-type="bibr" rid="scirp.114597-ref77">77</xref>]. The time dependence of the charge accumulation causes the characteristics of the β-dispersion [<xref ref-type="bibr" rid="scirp.114597-ref78">78</xref>]. In an experiment with sacrificed haddock muscle [<xref ref-type="bibr" rid="scirp.114597-ref79">79</xref>], the β-dispersion increases after a few hours of the sacrifice of the animal, showing the mechanism more connected to the cells than to the intact tissues. The high end of β-dispersion differs from the main effects of the range, called β1-dispersion caused from the torque of biological macro-molecules representing significant dipole moments, like proteins, orienting these against the disordering force of the thermal background [<xref ref-type="bibr" rid="scirp.114597-ref80">80</xref>]. However, the large molecules have limited possibility to follow the applied frequency and to grow further. Due to the massive heterogeneity of the biological tissues, this dispersion could have multiple effects, depending on the excited molecules. The conformational change of the present polymers [<xref ref-type="bibr" rid="scirp.114597-ref81">81</xref>], and macro-molecular relaxation with the exchange of the ionic effect in the vicinity of them [<xref ref-type="bibr" rid="scirp.114597-ref82">82</xref>]. The relaxation of amino-acid chains [<xref ref-type="bibr" rid="scirp.114597-ref83">83</xref>] and the proton fluctuations [<xref ref-type="bibr" rid="scirp.114597-ref84">84</xref>] also could have a role, which has no significant importance [<xref ref-type="bibr" rid="scirp.114597-ref85">85</xref>].</p><p>The upper tail of the β-dispersion continues to the δ-dispersion (~1 MHz - ~1 GHz), which represents another mechanism. The δ-dispersion occurs at a distinguished frequency range above the main β-dispersion [<xref ref-type="bibr" rid="scirp.114597-ref86">86</xref>] and is connected to the dipolar moments of proteins and other large molecules (like cellular organelles, biopolymers) [<xref ref-type="bibr" rid="scirp.114597-ref87">87</xref>]. This second Maxwell-Wagner dispersion (δ) is characteristic of suspended particles surrounded by a cell [<xref ref-type="bibr" rid="scirp.114597-ref88">88</xref>]. Proteins also cause these effects, protein-bound water and cell organelles such as mitochondria [<xref ref-type="bibr" rid="scirp.114597-ref89">89</xref>] [<xref ref-type="bibr" rid="scirp.114597-ref90">90</xref>].</p><p>Other relaxation processes like those of molecular side chains, bound water molecules, diffusion of charged molecules, and near membrane bonds, could be added to the δ-dispersion.</p><p>In addition, the β/δ-dispersion of the chosen carrier frequency orients the attack on the membrane reaction of the impedance selected cells [<xref ref-type="bibr" rid="scirp.114597-ref91">91</xref>] [<xref ref-type="bibr" rid="scirp.114597-ref92">92</xref>]. The optimally chosen carrier frequency is in the interval of intensive overlap of β and δ dispersion and using in a practical point of view is an ISM-frequency 13.56 MHz. (The ISM spectrum is reserved internationally for industrial, scientific, and medical use.) The model calculation also shows the importance of the 13.56 MHz [<xref ref-type="bibr" rid="scirp.114597-ref93">93</xref>]. The chosen modulation enhances the selection. The RF energy dominantly absorbs on the clustered transmembrane proteins (rafts) [<xref ref-type="bibr" rid="scirp.114597-ref94">94</xref>], exciting their receptors [<xref ref-type="bibr" rid="scirp.114597-ref95">95</xref>]. The excitation destructs the malignant cells dominantly in an apoptotic way [<xref ref-type="bibr" rid="scirp.114597-ref96">96</xref>] <xref ref-type="fig" rid="fig7">Figure 7</xref>.</p></sec><sec id="s2_3_5"><title>2.3.5. Support the Immune System</title><p>Homeostatic dynamic equilibrium is too complex for external constraints to be effective in repairing it. Tightly connected feedback mechanisms regulate the system, and the reaction of homeostatic control is against any simple constraints. An excellent example of this is the response to conventional hyperthermia, which aims to kill the tumor by the thermal effect of the absorbed energy. The heating is a valid objective, but unfortunately, homeostatic control mechanisms begin to correct this heating through various actions to maintain thermal balance. The most effective reaction is increased blood flow and perfusion, which aims to cool the heated lesion. However, this feedback carries a danger, as it increases the delivery of nutrients to the tumor and promotes metastasis by cell invasion into the bloodstream.</p><p>Consequently, any winning strategy to influence the dynamic equilibrium must work in conjunction with homeostatic controls, utilizing natural processes and supporting the immune system to recognize and destroy malignant cells throughout the body. The preparation of the immune system could be a perfect target for oncology treatments, instead of targeting cancer’s main strength, its proliferation. In this case, the lack of adaptive immunity to tumors can be revised, and the malignancy can be attacked by the host system itself.</p><p>The malignancy lacks the homeostatic complexity, turning the structural and dynamic conditions out of the healthy homeostatic network. Consequently, the challenging general tasks are fighting against cancer and the immune surveillance to support healthy homeostasis. The situation is complicated because the tumor cells hide their genetic information from the immune surveillance. They are well masked to avoid any systemic action against then, even the opposite: their demands are met as the system attempts to correct the irregularities. These “cheats” mislead the regulative actions and start to support the malignant cluster. Due to this falsely presented tumor status, the regular immune system does not act against it. The primary task is to present the signs of danger and stimulate the immune action to target and destroy the dangerous, highly proliferation cells.</p><p>The critical point is the immunological recognition of the malignancy. The immune system needs recognizable signs to direct its actions. However, the highly adaptive hiding strategy of malignant cells protects them from being identified by immune cells. A practical possibility for cancer invasion is the innate antitumor immune action of NK cells [<xref ref-type="bibr" rid="scirp.114597-ref97">97</xref>] [<xref ref-type="bibr" rid="scirp.114597-ref98">98</xref>]. Natural Killer (NK) cells do not need information through the host’s histocompatibility complex 1 (MHC-I) molecules and act in the absence of priming. The cytotoxic activity of NK potentially controls tumor growth [<xref ref-type="bibr" rid="scirp.114597-ref99">99</xref>]. To complicate the complement of the available positive effect of NK cells, it could also promote tumor progression and angiogenesis [<xref ref-type="bibr" rid="scirp.114597-ref100">100</xref>] by inducing Reactive Oxygen Species (ROS) dysfunction [<xref ref-type="bibr" rid="scirp.114597-ref101">101</xref>]. The NK-cell activation could be achieved with a low-frequency electric field [<xref ref-type="bibr" rid="scirp.114597-ref102">102</xref>] as well as by electroporation [<xref ref-type="bibr" rid="scirp.114597-ref103">103</xref>]. Intensive low-frequency components in the spectrum of the modulated treatment may trigger the NK activity, enriching the NK cells in the targeted, selected tumor [<xref ref-type="bibr" rid="scirp.114597-ref104">104</xref>].</p><p>As a standard in immune homeostatic regulation, all processes have promoters and suppressors, so in complexity, every effect maybe a friend or foe, which appears for NK cell activity as well [<xref ref-type="bibr" rid="scirp.114597-ref105">105</xref>].</p><p>The modulation also may effectively support the healthy additive immune effects with developing tumor-specific immune reactions. The challenge is how to present the genetic information of the malignancy in order to ignite the immune system. One of the possible solutions would be immunogenic cell death (ICD). The main point is the particular apoptosis starting with an external signal with the electric field, exciting the Trail R2 (DR5) death receptor with FADD-FAS complex, and the external signal through caspase (Cas) pathway goes to Cas8 and Cas3 finishing in apoptosis [<xref ref-type="bibr" rid="scirp.114597-ref106">106</xref>]. The external signal pathway connects to the internal mitochondrial apoptotic path as well, and forms Bax and cytochrome-c (point of no return) through Cas9, and Cas3 [<xref ref-type="bibr" rid="scirp.114597-ref107">107</xref>] finishing in apoptosis again [<xref ref-type="bibr" rid="scirp.114597-ref108">108</xref>]. The internally excited apoptosis also can follow the caspase-independent pathway through apoptosis-inducing factor (AIF) [<xref ref-type="bibr" rid="scirp.114597-ref104">104</xref>], so the apoptotic end can be reached by three different signal pathways. The XIAP protein could block the main external signal path, but the modulated RF blocks this XIAP activity with Septin4 [<xref ref-type="bibr" rid="scirp.114597-ref109">109</xref>], and with the same function, the SMAC/Diabolo [<xref ref-type="bibr" rid="scirp.114597-ref106">106</xref>].</p><p>All of the above processes develop damage-associated molecular patterns (DAMP) [<xref ref-type="bibr" rid="scirp.114597-ref106">106</xref>]; as a factor of the immunogenic cell death (ICD) [<xref ref-type="bibr" rid="scirp.114597-ref108">108</xref>]. The cancer cells, during its apoptosis, in addition to apoptotic bodies, liberates calreticulin (CRT, “eat me” signal), HMGB1 (“danger” signal), and heat-shock protein 70 (HSP70, “info” signal). These processes prepare antigen recognition producing antigen-presenting cells (APCs), which trigger the presence of helper (CD4+) and killer (CD8+) T-cells with explicit recognition of the malignant cells over the body [<xref ref-type="bibr" rid="scirp.114597-ref110">110</xref>]. This process allows the attack of distant micro- and macro-metastases in the system (abscopal effect), turning the local treatment to systemic [<xref ref-type="bibr" rid="scirp.114597-ref111">111</xref>] [<xref ref-type="bibr" rid="scirp.114597-ref73">73</xref>]. Noteworthy, the addition of dendritic cell medication may boost the overall immune effects [<xref ref-type="bibr" rid="scirp.114597-ref112">112</xref>] [<xref ref-type="bibr" rid="scirp.114597-ref113">113</xref>], and also an independent immune-stimulator works in harmony with modulated treatment [<xref ref-type="bibr" rid="scirp.114597-ref110">110</xref>]. <xref ref-type="fig" rid="fig8">Figure 8</xref> shows the schematic summary of the immune processes.</p></sec><sec id="s2_3_6"><title>2.3.6. Use Non-Thermal Effects</title><p>The amplitude modulation (AM, &lt;20 kHz) of the RF carrier frequency can</p><p>intensify the tumor-specific absorption as a part of the selection mechanism [<xref ref-type="bibr" rid="scirp.114597-ref114">114</xref>]. Despite that, by a theoretical approach of the little energy absorption [<xref ref-type="bibr" rid="scirp.114597-ref115">115</xref>], the membrane demodulation effect could cause damages in the cytosol [<xref ref-type="bibr" rid="scirp.114597-ref116">116</xref>], or trigger apoptotic signals and destroy the cell [<xref ref-type="bibr" rid="scirp.114597-ref106">106</xref>]. The result of the non-thermal processes is the change of the chemical or structural situation in the targeted (investigated) compound assembly [<xref ref-type="bibr" rid="scirp.114597-ref117">117</xref>]. The non-thermal processes form a new phase (structural or chemical), which is a phase transition. The transition does not use heat from the field but directly uses the work of the electric field for the actual changes by absorption. The energy from the applied electric field is absorbed by the electrons or any other particles in a compound. It could be done without temperature change, but the phase of the material alters and the entropy changes without adjusting the temperature.</p><p>This phenomenon, however, has two connections to the temperature:</p><p>1) We know that 100% energy efficacy does not exist (entropy law), so the “lost” energy (which is kept as internal energy of the system) produces heat as well.</p><p>2) We know that the changing temperature changes the conditions of the “non-thermal” processes, which are in this way sharply dependent on the temperature. In other words, the reaction rate changes in the simplest case by the Arrhenius law. This complex process, which contains the thermal dependence of the “non-thermal” effect (transition effect), is described by Eyring transition state theory, which is proposed to describe the hyperthermia where this complexity appears. In Eyring’s description, the thermal part is the same as in the Arrhenius law. Still, it has a part, which is a structural dependent factor, which could change without any temperature change, describing the “non-thermal effect” in complex systems.</p><p>The DNA damage is non-thermal. It is a phase transition, which has to be fixed by oxygen or by blocking the repairing enzymes. It does not need a temperature change at all. However, we know that both the oxygen-related or enzymatic fixing reactions (which conserves the break as it is) are temperature-dependent. The oxygen and enzyme reactions rapidly change according to temperature, mostly with Arrhenius law. The radiotherapy result has two parts: a temperature-independent and a temperature-dependent part, in the same way as this model describes the modulated electro-hyperthermia (mEHT) effect. This is why the same dose (Gray) is proposed for both the radiation processes (radiotherapy: ionizing; and mEHT: non-ionizing radiation).</p></sec></sec></sec><sec id="s3"><title>3. Results—Applications</title><p>The dynamic structures, performing random stationary stochastic self-organizing processes, have practical applications in recognizing the diseases [<xref ref-type="bibr" rid="scirp.114597-ref118">118</xref>] [<xref ref-type="bibr" rid="scirp.114597-ref119">119</xref>]. The self-similarity used modeling of cancer by fractals [<xref ref-type="bibr" rid="scirp.114597-ref120">120</xref>], described by a generalized model [<xref ref-type="bibr" rid="scirp.114597-ref121">121</xref>]; helping to evaluate the various images in oncology [<xref ref-type="bibr" rid="scirp.114597-ref122">122</xref>]. The collectivity of the organization of the biological systems could be monitored by the fractal concept [<xref ref-type="bibr" rid="scirp.114597-ref123">123</xref>]. The fractal geometry describes the pathological architecture of tumors and their growth mechanisms accompanying time-dependent processes [<xref ref-type="bibr" rid="scirp.114597-ref124">124</xref>], and prognostic value [<xref ref-type="bibr" rid="scirp.114597-ref125">125</xref>].</p><p>The pink-noise modulation applies the fractal knowledge to support the harmonization efforts of homeostatic regulation and induce stochastic resonance near the frequency of the carrier, to demodulate and excite the desired signal pathways. The intensive backing of the heathy influence on the cancer is mandatory because the tumors are out from the structural and dynamic coordination of the natural organizing control.</p><p>Technically a high frequency (RF) carrier delivers the well-chosen time pattern of the modulation, which transports the modulated signal to the body with a carefully fitted applicator [<xref ref-type="bibr" rid="scirp.114597-ref126">126</xref>]. The applicator is driven by a voltage signal formed, as shown in <xref ref-type="fig" rid="fig9">Figure 9</xref>.</p><p>The spectrum and the power density of the signal which drives the applicator are studied by decomposing the applicator voltage into a signal s ( t ) and a noise component n ( t ) :</p><p>u ( t ) = s ( t ) + n ( t ) , s ( t ) : = U 0 sin ω 0 t , n ( t ) : = m z ( t ) U 0 sin Ω t (37)</p><p>To calculate the power spectrum, we need to construct the autocorrelation</p><p>function u ( t ) :</p><p>u ( t ) ⊗ u ( t + τ ) : = lim T → ∞ 1 T ∫ − T T u ( t ) u ( t + τ ) d t (38)</p><p>where the sign ⊗ notes the necessary time integration of the signal with self in τ time-lag, and where we have taken into account a sufficiently sizeable averaging time. Considering the signal and noise components, we get:</p><p>u ( t ) ⊗ u ( t + τ ) : = s ( t ) ⊗ s ( t + τ ) + n ( t ) ⊗ n ( t + τ ) (39)</p><p>where the average of the function formed by the product of signal and noise approaches zero. First, the properties of the F { f ( t ) } Fourier transformation of the correlation function has to be calculated:</p><p>F { f ( t ) ⊗ g ( t + τ ) } = F ( ω ) G * ( ω ) , F { f ( t ) } = F ( ω ) , F { g ( t ) } = G ( ω ) (40)</p><p>where the ∗ star notation is a sign of conjugation. The Fourier transform is the pink noise in this approximation, so:</p><p>F { z ( t ) } = Z ( Ω ) = 1 i Ω (41)</p><p>thus the Fourier transform of noise:</p><p>F { n ( t ) } : = i 2 m U 0 [ Z ( | ω 0 − Ω | ) ] = i 2 m U 0 [ 1 i | ω 0 − Ω | ] (42)</p><p>consequently, the voltage power spectrum of the applicator:</p><p>Φ u u ( ω 0 ) : = F { u ( t ) ⊗ u ( t + τ ) } : = U 0 2 δ ( ω 0 − Ω ) + m 2 U 0 2 4 1 | ω 0 − Ω | (43)</p><p><xref ref-type="fig" rid="fig1">Figure 1</xref>0 shows the modulated signal spectrum.</p><p>According to the Wiener-Khinchin theorem [<xref ref-type="bibr" rid="scirp.114597-ref127">127</xref>], the square of the voltage amplitude in the frequency interval is:</p><p>Δ U 2 = ∫ ω ω + Δ Ω R u u ( Ω ) d Ω = ∫ ω + Δ Δ Ω ω + Δ Ω ( U 0 2 δ ( ω − Ω ) + m 2 U 0 2 4 1 | ω − Ω | ) d Ω = U 0 2 + m 2 U 0 2 4 ln Δ Ω Δ Δ Ω (44)</p><p>The second term of (44) shows that the square of the voltage amplitude can be extremely large near the carrier frequency, where the term tends to be infinite when Δ Δ Ω → 0 . It follows that the average potential:</p><p>Δ U e e : = Δ U 2 = U 0 2 + m 2 U 0 2 4 ln Δ Ω Δ Δ Ω (45)</p><p>And the field strength is represented as:</p><p>Δ E e f f = Δ U e f f d = 1 d U 0 2 + m 2 U 0 2 4 ln Δ Ω Δ Δ Ω (46)</p><p>where d is the distance between the electrodes. Of course, arbitrarily high performance cannot be physically realized. In practice, due to fast Fourier transformation, only a point spectrum is realized. Nevertheless, the field strength amplitude can be large enough, and so the modulation does not demand a high power for appropriate effect. In conclusion, the modulation effect transmits the low-frequency power spectrum of the pink noise near the 13.56 MHz carrier, highly efficiently, and forms two sidebands. The modulation results in very high amplitude field strength peaks near the carrier frequency.</p><sec id="s3_1"><title>3.1. Modulation for Adherent Bonds</title><p>The E-cadherin-β-catenin complex plays a crucial role in cellular adhesion [<xref ref-type="bibr" rid="scirp.114597-ref128">128</xref>]. The suppression of E-cadherin expression leads to dysfunction in cell-cell adhesion, which can cause local invasion following tumor development [<xref ref-type="bibr" rid="scirp.114597-ref53">53</xref>]. Loss of adhesion has been associated with increased invasiveness and metastasis of tumors [<xref ref-type="bibr" rid="scirp.114597-ref129">129</xref>]. On the other hand, the appropriate expression of E-cadherins has a vital role in tumor suppression [<xref ref-type="bibr" rid="scirp.114597-ref130">130</xref>]. The changes in cadherin expression may affect signal transduction leading to the cancer cells growing uncontrollably [<xref ref-type="bibr" rid="scirp.114597-ref131">131</xref>]. This challenge also appears in the bioelectric considerations [<xref ref-type="bibr" rid="scirp.114597-ref132">132</xref>] of cancer development. The junctions as intercellular connections, exchanging molecules in the same was as cadherins exchange molecules [<xref ref-type="bibr" rid="scirp.114597-ref133">133</xref>]. Importantly the adhesive connections have a vital role in tissue repairing [<xref ref-type="bibr" rid="scirp.114597-ref134">134</xref>].</p><p>Together with the collective and individual states, a third entity exists too: the pluripotent embryonic resting state (δ), stem cells that adapt themselves to their actual micro-environment [<xref ref-type="bibr" rid="scirp.114597-ref135">135</xref>]. Healthy cells are in a communicative network, maintaining the complexity of a well-controlled system, but the δ cells could form malignant transformations [<xref ref-type="bibr" rid="scirp.114597-ref133">133</xref>]. The malignant cells are mostly autonomic, having lost their “social” connections with other cells, and fighting for nutrients with every other cell, irrespective of their health status. The network state categorizes cells as connected or non-connected [<xref ref-type="bibr" rid="scirp.114597-ref136">136</xref>]. The non-connected cells also have a network but not by cell-cell bonds. The connections are formed by clusters of fighting cells trying to trigger the healthy neighbors to supply them (forced angiogenesis) [<xref ref-type="bibr" rid="scirp.114597-ref137">137</xref>].</p><p>The collective activity of cells emits pink noise, which is the noise of self-organization, and so it is the noise originated from the function of homeostasis. The essence of the pink noise of homeostasis is that the function of the organ-specific networked cells is regulated actively in their energy exchange in the harmony of the complex surveillance. Consequently, the variance of physiological signals remains constant over time.</p><p>The glycocalyx shell and cell membrane of a cancer cell are also different from those of a healthy cell. Because of this, the movement of proteins in the cell membrane by lateral diffusion is also more limited. Adherents are particular protein formulas that can move in the cell membrane by lateral diffusion. Contact between two cells can occur when two such proteins meet and chemically bond with each other by lateral diffusion <xref ref-type="fig" rid="fig1">Figure 1</xref>1. The re-established intercellular connections following mEHT have been were experimentally demonstrated [<xref ref-type="bibr" rid="scirp.114597-ref107">107</xref>] [<xref ref-type="bibr" rid="scirp.114597-ref138">138</xref>].</p><p>The glycocalyx shell of cancer cells is known to be charged highly negatively. This results in repulsion, so the attraction, which is one of the preconditions for cell recognition and the start of the adhesion process, cannot prevail. Consequently, the bond-formation is hampered by the strong negative charge of the cancer cell glycocalyx shell, so the formation of intercellular bonds and networking in malignancy is unlikely.</p><p>The condition for the formation of cellular collectivity is that the cell must be fixed with adherent bonds and junctions, which is largely missing in malignant tumors. The modulation/demodulation stochastic resonance of noise contains signals of very high amplitude, forcing the cell clusters to intercellular bonding, manifested in communication between cells, forming functional collectivity. The self-organizing signal transformed around a carrier produces large fields. The formed gradient promotes the adhesion bonding of neighboring cells. The pink-noise modulated electric field with a very high field strength which the amplitude is transformed near 13.56 MHz, helps build the bonds of adherent proteins <xref ref-type="fig" rid="fig1">Figure 1</xref>2.</p><p>The pink noise modulation transformed around 13.56 MHz creates a field strength gradient towards the cell contact site. Attraction by a gradient of field strength towards the point of contact occurs between the cells. Proteins are normally dipolar with polarization vector p . Therefore, a cataphoretic force F = ( p ∇ ) E acts to move the proteins toward the point of contact. The gradient</p><p>generates a high cataphoretic force <xref ref-type="fig" rid="fig1">Figure 1</xref>3 which promotes the contact of the cells. The process increases the likelihood of forming intercellular bonding by the connection of adherent proteins.</p><p>Due to the increased temperature in the contact point, the barrier between the protein electronic states could be easier overcome, so the moderate temperature helps the bonding. So it is expected that the thermal effect of mEHT helps the process. However, when the temperature is high, the break of bonds is more likely.</p></sec><sec id="s3_2"><title>3.2. Modulation for HSP</title><p>The heat-shock proteins (HSPs) are chaperons to help in stabilizing the dynamic equilibrium of the cells. They are named according to their molecular weight. The first observations have connected these proteins to the heat-stress [<xref ref-type="bibr" rid="scirp.114597-ref139">139</xref>], but later their expression for many other stresses was discovered [<xref ref-type="bibr" rid="scirp.114597-ref140">140</xref>] and intensive research into their role in health and diseases began [<xref ref-type="bibr" rid="scirp.114597-ref141">141</xref>]. The extreme stress effect promote HSP translocation to the cellular membrane [<xref ref-type="bibr" rid="scirp.114597-ref142">142</xref>] and liberation to the extracellular matrix. The HSP70 has dual function [<xref ref-type="bibr" rid="scirp.114597-ref143">143</xref>]: inside the cell protects it (chaperone function) and outside it is a danger signal to trigger immune reactions [<xref ref-type="bibr" rid="scirp.114597-ref144">144</xref>]. This feature makes these proteins possible therapeutic targets in various diseases [<xref ref-type="bibr" rid="scirp.114597-ref145">145</xref>] [<xref ref-type="bibr" rid="scirp.114597-ref146">146</xref>], and especially in oncology [<xref ref-type="bibr" rid="scirp.114597-ref147">147</xref>].</p><p>We elaborate on a theory that pink noise mEHT is suitable for enhanced HSP expression in the membrane and extracellular electrolyte. There are two important arguments for triggering the effect:</p><p>1. The carrier frequency is chosen in the range of the β/δ-dispersion, acting on lipid/protein bonds in the cell membrane.</p><p>2. The existence of high power amplitudes produced by the pink noise shifted to the carrier-frequency location.</p><p>The selection ensures that we excite the intended targeted cells with the high power pink-noise fluctuation near the carrier frequency. The RF-current density is increased at the cell membrane due to the β/δ-dispersion. The carrier would shift the pink noise into the β/δ-dispersion range, and there we expose the membrane to the pink noise. Streamlines pass from one cell to another at the points of contact of the cells. Electric fields with very high field strengths and gradients are generated in these places <xref ref-type="fig" rid="fig1">Figure 1</xref>4.</p><p>The connection points have high local SAR. However, due to the high field strength gradient enhanced by pink noise, a dielectrophoretic force also occurs, which moves half of this high SAR location to the micro-domains of the membrane thermo-sensor. The micro-domains are exposed to increased stress due to high power amplitudes. On the one hand, the stress effect is heat stress due to the high SAR and, on the other hand, mechanical deformation stress due to the high field strength gradient.</p><p>The β/δ-dispersion is used to produce HSP, and the selected target triggers the production of HSP70 for immune stimuli [<xref ref-type="bibr" rid="scirp.114597-ref149">149</xref>]. The immunomodulation of extracellular HSP70 makes it a promising candidate for vaccination of cancerous diseases by presenting malignant cells’ antigens [<xref ref-type="bibr" rid="scirp.114597-ref150">150</xref>]. The danger signal of extracellular HSP is an essential mediator for intercellular signaling and transport [<xref ref-type="bibr" rid="scirp.114597-ref151">151</xref>]. The molecule is part of the damage-associated molecular patternformed by immunogenic cell death, making a perfect way to produce CD8+ killer T-cells for a systemic fight against cancer.</p></sec><sec id="s3_3"><title>3.3. Modulation for Cellular Communication</title><p>The biological transformation of normal (β) to cancerous (α) is a communication phase transition which is explained on the level of individual cells [<xref ref-type="bibr" rid="scirp.114597-ref136">136</xref>]. The starting point of Szent-Gyorgyi is an etiological approach: the disappearance of cellular collectivity [<xref ref-type="bibr" rid="scirp.114597-ref53">53</xref>]. The β → α state change driven by changes of the micro-environment of the malignant cells [<xref ref-type="bibr" rid="scirp.114597-ref4">4</xref>].</p><p>The division naturally needs higher energy income than the regular life of the cells. The cytoskeleton polymerization during the cell division breaks the networking connections, allowing the free formation of the new cytoskeleton and intensifying support of the microenvironment of the dividing cells by higher diffusion in the free electrolyte. After finishing the division, the cells are reconnected, the network control activates again. The internal energy resources promote the appropriate, satisfactory amount of energy. Together with the environmental sources, the cells build up the daughter cells with the healthy cellular division [<xref ref-type="bibr" rid="scirp.114597-ref152">152</xref>]. However, the malignant cells have no reserves for the extreme energy demand to proliferate [<xref ref-type="bibr" rid="scirp.114597-ref153">153</xref>]. The usual healthy process does not work in malignant proliferation. The tumor cells do not return to the network. They remain as individuals and continue the proliferation. One explanation concentrates on the dielectric changes in the cell microenvironment [<xref ref-type="bibr" rid="scirp.114597-ref154">154</xref>], which is high in the cancerous process in vivid form [<xref ref-type="bibr" rid="scirp.114597-ref155">155</xref>]. Noisy communication can also cause cancer. This can occur when the relative arrangement of the cells does not allow for an interaction leading to cyclic symmetry, like requested [<xref ref-type="bibr" rid="scirp.114597-ref34">34</xref>]. From our perspective, this can be interpreted, meaning that if the symmetry is not cyclic, it is divisible. Otherwise, it is not, which supports the idea, that the cellular position has a vital role in favoring the malignant proliferation [<xref ref-type="bibr" rid="scirp.114597-ref156">156</xref>].</p></sec></sec><sec id="s4"><title>4. Discussion—Cancer Therapy</title><p>The strategy to eliminate the cancerous processes focuses on the weakest point of the tumor: individualism. The missing overall network makes them vulnerable, as they are alone in fighting the stress.</p><p>The malignant development misses the healthy homeostatic regulation. The systemic controls do not work. Their extreme energy demand drives their systemic effect. The cancerous process concentrates on intensive proliferation and uses healthy hosts to support it. This complex process misleads the healthy host, presenting their actions as normal energy-demand for healing the lesion like a wound (as was described shown 25 years ago [<xref ref-type="bibr" rid="scirp.114597-ref88">88</xref>] ). Cancer presents itself as trying to heat, and the system cannot recognize the “cheating” due to the hidden identification signs. This shows that the entire malignant process is essentially a wound repair process [<xref ref-type="bibr" rid="scirp.114597-ref157">157</xref>]. The idea has been investigated more recently, with comparisons between the hallmarks of the two processes [<xref ref-type="bibr" rid="scirp.114597-ref158">158</xref>], demonstrating the role of this mechanism in the formation of metastases [<xref ref-type="bibr" rid="scirp.114597-ref159">159</xref>]. The bio-system falsely recognizes the tumor-like wound [<xref ref-type="bibr" rid="scirp.114597-ref160">160</xref>] and stimulates its environment to heal the irregularity (meaning to produce cells to heal).</p><p>The permanent reparation demand depletes the available stem cells, [<xref ref-type="bibr" rid="scirp.114597-ref161">161</xref>] [<xref ref-type="bibr" rid="scirp.114597-ref162">162</xref>], and is emphasizes a different repair pathway: the proto-oncogenes are activated, and malignant transformation could happen, inducing the clinical manifestation of cancer [<xref ref-type="bibr" rid="scirp.114597-ref163">163</xref>]. The malignant transformation of the wound results in the secretion of proto-oncogenes [<xref ref-type="bibr" rid="scirp.114597-ref164">164</xref>] [<xref ref-type="bibr" rid="scirp.114597-ref165">165</xref>] [<xref ref-type="bibr" rid="scirp.114597-ref166">166</xref>], and intensive capture and stimulation of the stem-cells from other places [<xref ref-type="bibr" rid="scirp.114597-ref167">167</xref>] [<xref ref-type="bibr" rid="scirp.114597-ref168">168</xref>].</p><p>Ignoring the healthy regulations and the collectivity of the host tissue has some structural and temporal signs to recognize it. The structure of the individual cells is more disordered than the networked healthy tissue, and the intensive individual metabolic demand changes the structure of extracellular electrolyte. The permanent cellular division periodically collapses the cell’s actual cytoskeleton and builds up new ones again, decomposed by the subsequent fission and repolymerization. This changes the cellular form individually, and the active dynamism, which differs from the healthy regulated one, is expressed in the noise of the tumor processes. The noisy difference is measurable by electric impedance [<xref ref-type="bibr" rid="scirp.114597-ref169">169</xref>], detecting the “color” of the noise. As shown above, the “color” is determined by the self-similarity scaling exponent of power density by frequency. The measured exponent decreases from the near-1 (pink noise), depending on the weakened cellular interactions, and so the autonomy is field. The same change was observed in the autocorrelation [<xref ref-type="bibr" rid="scirp.114597-ref170">170</xref>], lowering the function value at 1/e, so the correlation was decreasing, which characterizes the trend towards autonomy. The weakness of the malignant process is this autonomy when the cells are alone to fight against any external stresses. So the weakness, which we have to use [<xref ref-type="bibr" rid="scirp.114597-ref171">171</xref>], is the missing network, the missing collective harmony. The individualism of the cells is similar to atavistic reverse development in the evolutionary meaning. The atavistic model could be used as a starting point, but this model does not consider all the crucial details (hallmarks) that keep the single-celled units of cancer development alive [<xref ref-type="bibr" rid="scirp.114597-ref172">172</xref>]. The wound healing support of the host tissue is missing from the atavistic model, and so it is not applicable. However, the proper noise application places the theranostic key in the hand of the therapist. The noise spectrum is measurable for diagnosis [<xref ref-type="bibr" rid="scirp.114597-ref171">171</xref>], and the pink noise as a homeostatic harmony character could make a forceful selected harmonization factor, which harmonizes the precancerous cells, rebinding their broken intercellular connections [<xref ref-type="bibr" rid="scirp.114597-ref107">107</xref>] [<xref ref-type="bibr" rid="scirp.114597-ref173">173</xref>], forcing back the healthy order. When the rebinding is impossible, the harmonizing force “softly” destroys the cells, exposing their genetic content for antigen presentation, and igniting the normal immune reaction against the malignancy. In other words, the mask falls off.</p><p>The practice of modulated electromagnetic applications connects the knowledge of hyperthermia with electromagnetic effects. The modulated electro-hyperthermia (mEHT, trade name oncothermia&#174;) has used this method for years in a broad application for various tumors. Below we summarize the most crucial information-set about its processes and results, showing publications.</p><p>Numerous practical applications proved the feasibility of the mEHT treatments. Based on some principal considerations, the method uses the thermal and non-thermal effects [<xref ref-type="bibr" rid="scirp.114597-ref116">116</xref>] in a synergy. The non-thermal effects are connected to the cellular membranes [<xref ref-type="bibr" rid="scirp.114597-ref114">114</xref>] [<xref ref-type="bibr" rid="scirp.114597-ref115">115</xref>], emphasizing the physical potential of the amplitude modulation [<xref ref-type="bibr" rid="scirp.114597-ref174">174</xref>]. The strong connection between the thermal-factors and electric effects involves the similarities between their actions [<xref ref-type="bibr" rid="scirp.114597-ref175">175</xref>], and the strong synergy was indeed observed in vivo [<xref ref-type="bibr" rid="scirp.114597-ref176">176</xref>]. The absorbed power develops the temperature [<xref ref-type="bibr" rid="scirp.114597-ref177">177</xref>] which has a selective heating possibility [<xref ref-type="bibr" rid="scirp.114597-ref178">178</xref>] by electric inhomogeneities and depends on the technical solution of the coupling [<xref ref-type="bibr" rid="scirp.114597-ref179">179</xref>].</p><p>The temperature development is a complex process [<xref ref-type="bibr" rid="scirp.114597-ref180">180</xref>], and connected to the dosing in treatment practice [<xref ref-type="bibr" rid="scirp.114597-ref181">181</xref>] [<xref ref-type="bibr" rid="scirp.114597-ref182">182</xref>].</p><p>The extracellular action complexly interconnects the electric field with the thermal effects [<xref ref-type="bibr" rid="scirp.114597-ref183">183</xref>]. The thermal noise influences the electric field effect [<xref ref-type="bibr" rid="scirp.114597-ref22">22</xref>] [<xref ref-type="bibr" rid="scirp.114597-ref184">184</xref>], but it does not block the intracellular processes [<xref ref-type="bibr" rid="scirp.114597-ref185">185</xref>]. The modulation technology has been described in oncology [<xref ref-type="bibr" rid="scirp.114597-ref186">186</xref>].</p><p>The RF energy is predominantly absorbed on the clustered transmembrane proteins (rafts) [<xref ref-type="bibr" rid="scirp.114597-ref94">94</xref>], exciting their receptors [<xref ref-type="bibr" rid="scirp.114597-ref94">94</xref>] [<xref ref-type="bibr" rid="scirp.114597-ref187">187</xref>] [<xref ref-type="bibr" rid="scirp.114597-ref188">188</xref>]. The excitation damages the malignant cells dominantly in an apoptotic way [<xref ref-type="bibr" rid="scirp.114597-ref105">105</xref>] [<xref ref-type="bibr" rid="scirp.114597-ref149">149</xref>]. The mEHT promoted extracellular HSP70 supports the apoptotic processes [<xref ref-type="bibr" rid="scirp.114597-ref108">108</xref>]. The membrane rafts are the key elements of energy absorption [<xref ref-type="bibr" rid="scirp.114597-ref189">189</xref>], which is an energy intake in the nano-range [<xref ref-type="bibr" rid="scirp.114597-ref148">148</xref>]. The whole mEHT process is immunogenic [<xref ref-type="bibr" rid="scirp.114597-ref190">190</xref>]. The method may be applied complementary to radiotherapy [<xref ref-type="bibr" rid="scirp.114597-ref191">191</xref>] [<xref ref-type="bibr" rid="scirp.114597-ref192">192</xref>]; an example is the resensitization of the radioresistant pancreatic cells for further treatment [<xref ref-type="bibr" rid="scirp.114597-ref193">193</xref>]. The complementary application of mEHT with chemotherapy has also been successful [<xref ref-type="bibr" rid="scirp.114597-ref194">194</xref>] [<xref ref-type="bibr" rid="scirp.114597-ref195">195</xref>].</p><p>A recent review summarizes the molecular biology background of the tumor damage mechanisms revealed in cancer models [<xref ref-type="bibr" rid="scirp.114597-ref196">196</xref>].</p><p>In the clinical application, the safety of the method was investigated in one of the most sensitive organs, the brain. The prospective safety study involved the dose-expansion for non-invasive transcranial therapy in 3<sup>rd</sup> and 4<sup>th</sup> line, advanced; relapsed high-grade gliomas and proved the safety even in the daily applications [<xref ref-type="bibr" rid="scirp.114597-ref197">197</xref>]. Efficacy studies validated the feasibility of this method for such a short survival, high-mortality stage of the disease, [<xref ref-type="bibr" rid="scirp.114597-ref198">198</xref>] [<xref ref-type="bibr" rid="scirp.114597-ref199">199</xref>] [<xref ref-type="bibr" rid="scirp.114597-ref200">200</xref>]. The special safety [<xref ref-type="bibr" rid="scirp.114597-ref201">201</xref>] and efficacy [<xref ref-type="bibr" rid="scirp.114597-ref202">202</xref>] studies in advanced non-small cell lung cancer patients justified the use of mEHT in this type of malignancy as well. The analyses of brain [<xref ref-type="bibr" rid="scirp.114597-ref203">203</xref>] and lung [<xref ref-type="bibr" rid="scirp.114597-ref204">204</xref>] studies support the economic advantage of mEHT. The applications in gastrointestinal tracts like colon, [<xref ref-type="bibr" rid="scirp.114597-ref205">205</xref>], rectum [<xref ref-type="bibr" rid="scirp.114597-ref206">206</xref>], liver [<xref ref-type="bibr" rid="scirp.114597-ref207">207</xref>], and pancreas [<xref ref-type="bibr" rid="scirp.114597-ref208">208</xref>] [<xref ref-type="bibr" rid="scirp.114597-ref209">209</xref>] demonstrated the versatile functions of the mEHT method. The relapsed, refractory, or progressive heavily treated ovarian cancer [<xref ref-type="bibr" rid="scirp.114597-ref210">210</xref>], and the advanced, recurrent cervix uteri [<xref ref-type="bibr" rid="scirp.114597-ref211">211</xref>] [<xref ref-type="bibr" rid="scirp.114597-ref212">212</xref>] were also successfully treated with complementary combinations of conventional chemoradiotherapy and mEHT, obtaining low toxicity and longer survival, with improved quality of life [<xref ref-type="bibr" rid="scirp.114597-ref213">213</xref>]. The applicability for sarcomas in complementary therapy protocols was also proven [<xref ref-type="bibr" rid="scirp.114597-ref214">214</xref>] [<xref ref-type="bibr" rid="scirp.114597-ref215">215</xref>]. The immunogenic influence in combination with other immune supports is also remarkable [<xref ref-type="bibr" rid="scirp.114597-ref216">216</xref>] and realizes tumor-specific immune reactions for distant metastases (abscopal effect) [<xref ref-type="bibr" rid="scirp.114597-ref217">217</xref>] [<xref ref-type="bibr" rid="scirp.114597-ref218">218</xref>]. These observations orient the treatment to tumor-directed immunotherapy [<xref ref-type="bibr" rid="scirp.114597-ref219">219</xref>] and could be a basis of the personalized medicine [<xref ref-type="bibr" rid="scirp.114597-ref220">220</xref>]. Remarkable application of mEHT for the peritoneal carcinomatosis with malignant ascites, [<xref ref-type="bibr" rid="scirp.114597-ref221">221</xref>], which extends the study focus to ascites cases.</p><p>Recently a review had summarized the clinical evidence of mEHT for the practicing oncologists [<xref ref-type="bibr" rid="scirp.114597-ref222">222</xref>], and an application guideline was published by an international collective [<xref ref-type="bibr" rid="scirp.114597-ref223">223</xref>].</p><p>Notably, most studies have single-arm protocols, which have inherent complications in evaluating the mEHT method. The patients involved in these studies are in relapsed advanced stages when the conventional therapies are limited or have failed. Collecting a cohort for reference at this stage is exceptionally challenging and, in most cases, impossible [<xref ref-type="bibr" rid="scirp.114597-ref224">224</xref>]. However, the evaluation of single-arm trials has specialties, which could improve the level of evidence of the results. The simplest one is the comparison of the single-arm results from different studies with the same protocol. For example, the comparison of advanced glioblastoma (<xref ref-type="fig" rid="fig1">Figure 1</xref>5) [<xref ref-type="bibr" rid="scirp.114597-ref225">225</xref>] [<xref ref-type="bibr" rid="scirp.114597-ref226">226</xref>] [<xref ref-type="bibr" rid="scirp.114597-ref227">227</xref>] [<xref ref-type="bibr" rid="scirp.114597-ref200">200</xref>] [<xref ref-type="bibr" rid="scirp.114597-ref203">203</xref>], and pancreas (<xref ref-type="fig" rid="fig1">Figure 1</xref>6) [<xref ref-type="bibr" rid="scirp.114597-ref228">228</xref>] [<xref ref-type="bibr" rid="scirp.114597-ref229">229</xref>] [<xref ref-type="bibr" rid="scirp.114597-ref225">225</xref>] [<xref ref-type="bibr" rid="scirp.114597-ref230">230</xref>] [<xref ref-type="bibr" rid="scirp.114597-ref231">231</xref>], studies shows the significant difference of the common median from the historical or database control.</p><p>Other analysis of single-arm results uses the self-similarity of living processes [<xref ref-type="bibr" rid="scirp.114597-ref232">232</xref>] [<xref ref-type="bibr" rid="scirp.114597-ref233">233</xref>], building up the reference arm from the parameters of the active single-arm [<xref ref-type="bibr" rid="scirp.114597-ref234">234</xref>] [<xref ref-type="bibr" rid="scirp.114597-ref235">235</xref>].</p></sec><sec id="s5"><title>5. Conclusion</title><p>The modulation of radiofrequency carriers causes stochastic resonances, which act mainly on enzymatic processes. The demodulation is also effectively performed by stochastic resonance, which allows the low-frequency modulation information to be delivered selectively to the cancerous cells. There are as many resonant frequencies as there are enzymatic reactions that exist.</p><p>The modulation intensively changes the paradigm of cancer treatment. It boosts the healthy network and selectively destroys the malignant cells. The cell-killing process is immunogenic, allowing for the release of genetic information</p><p>in a molecular pattern (DAMP), which could form antigen presenting cells and develop tumor-specific immune reactions. The modulated signal is a complex mixture of non-thermal electron excitation for chemical reactions, and thermal boosting of the enzymatic reactions.</p><p>The complex homeostatic network has a cyclic symmetry which controls the balance and the apoptotic processes. The living cellular structures are open to the effects of energy, requiring energy input, followed by the output of waste. This organized transport system is not possible without direct cellular communication (no “social signal”). The cyclic topological order makes the noiseless inter- and intra-cellular communications possible despite the thermal noise background.</p><p>The malignant transformation breaks the organized transport system and seeks to build up new structures for the new demands. However, there are fundamental differences: the healthy construction is driven by the collective signal and seeks to optimize the energy-use for highest efficacy, while the malignant construction is only driven by the topology and physics of the mass number of individual, competing cells, irrespective of the efficacy of the energy conversion. The new structure modifies the cell-cell communications and arranges the malignant cellular microenvironment suitable for the autonomic actions. The topology in this meaning has significant diagnostic (pathologic) meaning: the more the pattern of tumor (networking “mesh” and form of the cells) resembles the healthy cells, the less malignant the tumor is.</p><p>The modulation affects the malignant construction in various ways:</p><p>1) boosts the healthy network;</p><p>2) limits the autonomy of the cells;</p><p>3) selects the malignant cells and targets them with resonance energy-absorption;</p><p>4) excites selected molecules, influencing and promoting the enzymatic processes;</p><p>5) supports the immune system and triggers selective antitumor effects;</p><p>6) regenerates the lost intercellular adherent bonds, and with this limits the invasion of the malignant cells;</p><p>7) frees the HSP70 extracellularly to carry genetic information about the malignant cell to antigen-presenting cells;</p><p>8) supports the cellular communications and the synchrony of the cells.</p><p>The modulation signal is a time-fractal representing the systemic homeostatic fluctuations. It is self-similar, having 1/f noise of the power density. It might promote the-establishing the lost cellular communications or stimulate apoptosis of the cells which remain individual.</p><p>The modulation principles to support the healthy processes have broad feasibility to treat the patients. The therapy is a complex, multi-component clinical process, where one of the factors is the modulated electro-hyperthermia (mEHT). The mEHT has proved its exceptional capability to treat late-stage, relapsed cancerous tumors, complementary to any other conventional therapies. In instances where there are no further treatment options available, mEHT could be applied as monotherapy, or in some cases, could desensitize tumors to the previously ineffective conventional treatment.</p></sec><sec id="s6"><title>Acknowledgments</title><p>This work was supported by the Hungarian National Research Development and Innovation Office PIACI KFI grant: 2019-1.1.1-PIACI-KFI-2019-00011.</p></sec><sec id="s7"><title>Conflicts of Interest</title><p>The author declares no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s8"><title>Cite this paper</title><p>Szasz, A. (2022) Time-Fractal Modulation—Possible Modulation Effects in Human Therapy. Open Journal of Biophysics, 12, 38-87. https://doi.org/10.4236/ojbiphy.2022.121003</p></sec></body><back><ref-list><title>References</title><ref id="scirp.114597-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Trigos, A.S., Pearson, R.B., Papenfuss, A.T., et al. (2016) Altered Interactions between Unicellular and Multicellular Genes Drive Hallmarks of Transformation in a Diverse Range of Solid Tumors. PNAS, 114, 6406-6411. https://doi.org/10.1073/pnas.1617743114</mixed-citation></ref><ref id="scirp.114597-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Davidson, C.D., Wang, W.Y., Zaimi, I., et al. (2019) Cell Force-Mediated Matrix Reorganization Underlies Multicellular Network Assembly. Scientific Reports, 9, Article No. 12. https://doi.org/10.1038/s41598-018-37044-1</mixed-citation></ref><ref id="scirp.114597-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Balmain, A., Gray, J. and Ponder, B. (2014) The Genetics and Genomics of Cancer. Nature Genetics Supplement, 33, 238-244. https://doi.org/10.1038/ng1107</mixed-citation></ref><ref id="scirp.114597-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Szigeti, G.P., Szasz, O. and Hegyi, G. (2017) Connections between Warburg’s and Szentgyorgyi’s Approach about the Causes of Cancer. Journal of Neoplasm, 1, 1-13.</mixed-citation></ref><ref id="scirp.114597-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Hanahan, D. and Weinberg, R.A. (2000) The Hallmarks of Cancer. Cell, 100, 57-70. https://doi.org/10.1016/S0092-8674(00)81683-9</mixed-citation></ref><ref id="scirp.114597-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Hanahan, D. and Weinberg, R.A. (2011) Hallmarks of Cancer: The Next Generation. Cell, 144, 646-674. https://doi.org/10.1016/j.cell.2011.02.013</mixed-citation></ref><ref id="scirp.114597-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Dyas, F.G. (1928) Chronic Irritation as a Cause of Cancer. JAMA, 90, 457. https://doi.org/10.1001/jama.1928.92690330003008c</mixed-citation></ref><ref id="scirp.114597-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Dvorak, H.F. (1986) Tumors: Wounds That Do Not Heal, Similarities between Tumor Stroma Generation and Wound Healing. The New England Journal of Medicine, 315, 1650-1659. https://doi.org/10.1056/NEJM198612253152606</mixed-citation></ref><ref id="scirp.114597-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Platz, E.A. and Marzo, A.M. (2004) Epidemiology of Inflammation and Prostate Cancer. The Journal of Urology, 171, S36-S40. https://doi.org/10.1097/01.ju.0000108131.43160.77</mixed-citation></ref><ref id="scirp.114597-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Punyiczki, M. and Fesus, L. (1998) Heat Shock and Apoptosis: The Two Defense Systems of the Organisms May Have Overlapping Molecular Elements. Annals of the New York Academy of Sciences, 951, 67-74. https://doi.org/10.1111/j.1749-6632.1998.tb08978.x</mixed-citation></ref><ref id="scirp.114597-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Aktipis, C.A., Bobby, A.M., Jansen, G., et al. (2015) Cancer across the Tree of Life: Cooperation and Cheating in Multicellularity. Philosophical Transactions of the Royal Society B, 370, Article ID: 20140219. https://doi.org/10.1098/rstb.2014.0219</mixed-citation></ref><ref id="scirp.114597-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Varma, R. and Selman, J.S., (1991) Techniques for Characterisation of Electrodes and Electrochemical Processes. John Wiley &amp; Sons, New York.</mixed-citation></ref><ref id="scirp.114597-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Jacobsen, T. and West, K. (1995) Diffusion Impedance for Planar, Cylindrical, and Spherical Geometry. Electrochimica Acta, 40, 255-262. https://doi.org/10.1016/0013-4686(94)E0192-3</mixed-citation></ref><ref id="scirp.114597-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Robinson, F.N.H. (1962) Noise in Electrical Circuits. Oxford Univ. Press, London.</mixed-citation></ref><ref id="scirp.114597-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Goldup, A., Ohki, S. and Danielli, J.F. (1970) Black Lipid Films. Recent Progress in Surface Science, 3, 193-261. https://doi.org/10.1016/B978-0-12-571803-5.50013-4</mixed-citation></ref><ref id="scirp.114597-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Goldman, D.E. (1943) Potential, Impedance, and Rectification in Membranes. Journal of General Physiology, 27, 37-60. https://doi.org/10.1085/jgp.27.1.37</mixed-citation></ref><ref id="scirp.114597-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Ramachandran, S., Blick, R.H. and van der Weide, D.W. (2010) Radio-Frequency Rectification on Membrane Bound Pores. Nanotechnology, 1, 75201. https://doi.org/10.1088/0957-4484/21/7/075201</mixed-citation></ref><ref id="scirp.114597-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Tanaka, A. and Tokimasa, T. (1999) Theoretical Background for Inward Rectification. Tokai Journal of Experimental and Clinical Medicine, 24, 147-153.</mixed-citation></ref><ref id="scirp.114597-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Szendro, P., Vincze, G. and Szasz, A. (2001) Bio-Response to White Noise Excitation. Electro- and Magnetobiology, 20, 215-229. https://doi.org/10.1081/JBC-100104145</mixed-citation></ref><ref id="scirp.114597-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Kerr, W.T., Anderson, A., Lau, E.P., et al. (2012) Automated Diagnosis of Epilepsy Using EEG Power Spectrum. Epilepsia, 53, e189-e192.</mixed-citation></ref><ref id="scirp.114597-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Dave, K., Davtyan, A., Papoian, G.A., et al. (2015) Environmental Fluctuations and Stochastic Resonance in Protein Folding. ChemPhysChem, 17, 1341-1348. https://doi.org/10.1002/cphc.201501041</mixed-citation></ref><ref id="scirp.114597-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Astumian, R.D., Weaver, J.C. and Adair, R.K. (1995) Rectification and Signal Averaging of Weak Electric Fields by Biological Cells. Proceedings of the National Academy of Sciences of the United States of America, 92, 3740-3743. https://doi.org/10.1073/pnas.92.9.3740</mixed-citation></ref><ref id="scirp.114597-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Vincze, Gy., Szasz, A. and Szasz, N. (2005) On the Thermal Noise Limit of Cellular Membranes. Bioelectromagnetics, 26, 28-35. https://doi.org/10.1002/bem.20051</mixed-citation></ref><ref id="scirp.114597-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Winfree, A.T. (1984) The Prehistory of the Belousov-Zhabotinsky Oscillator. Journal of Chemical Education, 61, 661-663. https://doi.org/10.1021/ed061p661</mixed-citation></ref><ref id="scirp.114597-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Hudson, J.L. and Mankin, J.C. (1981) Chaos in the Belousov-Zhabotinskii Reaction. The Journal of Chemical Physics, 74, 6171-6177. https://doi.org/10.1063/1.441007</mixed-citation></ref><ref id="scirp.114597-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Matsumoto, K. and Tsuda, I. (1983) Noise-Induced Order. Journal of Statistical Physics, 31, 87-106. https://doi.org/10.1007/BF01010923</mixed-citation></ref><ref id="scirp.114597-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Taylor, A.F., Tinsley, M.R., Wang, F., et al. (2009) Dynamical Quorum Sensing and Synchronization in Large Populations of Chemical Oscillators. Science, 323, 614-617. https://doi.org/10.1126/science.1166253</mixed-citation></ref><ref id="scirp.114597-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Hunt, T. and Schooler, J.W. (2019) The Easy Part of the Hard Problem: A Resonance Theory of Consciousness. Frontiers in Human Neuroscience, 13, Article No. 378. https://doi.org/10.3389/fnhum.2019.00378</mixed-citation></ref><ref id="scirp.114597-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">Voss, R.F. and Clarke, J. (1975) “1/f Noise” in Music and Speech, Nature, 28, 317-318. https://doi.org/10.1038/258317a0</mixed-citation></ref><ref id="scirp.114597-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">Colley, I.D. and Dean, R.T. (2019) Origins of 1/f Noise in Human Music Performance from Short-Range Autocorrelations Related to Rhythmic Structures. PLoS ONE, 1, e0216088. https://doi.org/10.1371/journal.pone.0216088</mixed-citation></ref><ref id="scirp.114597-ref31"><label>31</label><mixed-citation publication-type="book" xlink:type="simple">Chorvatova, A. and Chorvat Jr., D. (2011) Coherent Resonant Properties of Cardiac Cells. In: Min, M., Ed., Cardiac Pacemakers—Biological Aspects, Clinical Applications and Possible Complications, IntechOpen, London, 25-45. https://doi.org/10.5772/23292</mixed-citation></ref><ref id="scirp.114597-ref32"><label>32</label><mixed-citation publication-type="other" xlink:type="simple">Schr&amp;ouml;dinger, E. (1951) Science and Humanism. Cambridge University Press, Cambridge.</mixed-citation></ref><ref id="scirp.114597-ref33"><label>33</label><mixed-citation publication-type="other" xlink:type="simple">Raff, M.C. (1992) Social Controls on Cell Survival and Death. Nature, 356, 397-400. https://doi.org/10.1038/356397a0</mixed-citation></ref><ref id="scirp.114597-ref34"><label>34</label><mixed-citation publication-type="other" xlink:type="simple">Von Neumann, J. (1959) The Computer and the Brain. Yale University Press, London.</mixed-citation></ref><ref id="scirp.114597-ref35"><label>35</label><mixed-citation publication-type="other" xlink:type="simple">Szendro, P., Vincze, G. and Szasz, A. (2001) Pink Noise Behaviour of the Bio-Systems. European Biophysics Journal, 30, 227-231. https://doi.org/10.1007/s002490100143</mixed-citation></ref><ref id="scirp.114597-ref36"><label>36</label><mixed-citation publication-type="other" xlink:type="simple">Goldenfeld, N. and Woese, C. (2010) Life Is Physics: Evolution as a Collective Phenomenon Far from Equilibrium.</mixed-citation></ref><ref id="scirp.114597-ref37"><label>37</label><mixed-citation publication-type="other" xlink:type="simple">West, B.J. and West, D. (2011) Are Allometry and Macroevolution Related? Physica A: Statistical Mechanics and Its Applications, 390, 1733-1736. https://doi.org/10.1016/j.physa.2010.11.031</mixed-citation></ref><ref id="scirp.114597-ref38"><label>38</label><mixed-citation publication-type="other" xlink:type="simple">West, G.B. and Brown, J.H. (2005) The Origin of Allometric Scaling Laws in Biology from Genomes to Ecosystems: Towards a Quantitative Unifying Theory of Biological Structure and Organization. Journal of Experimental Biology, 208, 1575-1592. https://doi.org/10.1242/jeb.01589</mixed-citation></ref><ref id="scirp.114597-ref39"><label>39</label><mixed-citation publication-type="other" xlink:type="simple">H&amp;auml;usser, M. (2001) Synaptic Function: Dendritic Democracy. Current Biology, 11, R10-R12. https://doi.org/10.1016/S0960-9822(00)00034-8</mixed-citation></ref><ref id="scirp.114597-ref40"><label>40</label><mixed-citation publication-type="other" xlink:type="simple">Das, Neves, R.P., Jones, N.S. andreu, L., Gupta, R., Enver, T. and Iborra, F.J. (2010) Connecting Variability in Global Transcription Rate to Mitochondrial Variability. PLOS Biology, 8, e1000560. https://doi.org/10.1371/journal.pbio.1000560</mixed-citation></ref><ref id="scirp.114597-ref41"><label>41</label><mixed-citation publication-type="other" xlink:type="simple">Johnston, I.G., Gaal, B., das, Neves, R.P., Enver, T., Iborra, F.J. and Jones, N.S. (2012) Mitochondrial Variability as a Source of Extrinsic Cellular Noise. PLOS Computational Biology, 8, e1002416. https://doi.org/10.1371/journal.pcbi.1002416</mixed-citation></ref><ref id="scirp.114597-ref42"><label>42</label><mixed-citation publication-type="other" xlink:type="simple">Alberts, B., Alexander, J., Julian, L., Martin, R., Keith, R. and Peter, W. (1994). Molecular Biology of the Cell. Garland Publishing Inc., New York.</mixed-citation></ref><ref id="scirp.114597-ref43"><label>43</label><mixed-citation publication-type="other" xlink:type="simple">Dawkins, R. (1976) The Selfish Gene. Oxford University Press, Oxford.</mixed-citation></ref><ref id="scirp.114597-ref44"><label>44</label><mixed-citation publication-type="other" xlink:type="simple">McAvoy, A. and Hauert, C. (2016) Autocratic Strategies for Iterated Games with Arbitrary Action Spaces. PNAS, 113, 3573-3578. https://doi.org/10.1073/pnas.1520163113</mixed-citation></ref><ref id="scirp.114597-ref45"><label>45</label><mixed-citation publication-type="other" xlink:type="simple">McAvoy, A. and Hauert, C. (2016) Autocratic Strategies for Alternating Games. Theoretical Population Biology, 113, 13-22. https://doi.org/10.1016/j.tpb.2016.09.004</mixed-citation></ref><ref id="scirp.114597-ref46"><label>46</label><mixed-citation publication-type="other" xlink:type="simple">Nowak, M.A. and Sigmund, K. (1994) The Alternating Prisoner’s Dilemma. Journal of Theoretical Biology, 168, 219-226. https://doi.org/10.1006/jtbi.1994.1101</mixed-citation></ref><ref id="scirp.114597-ref47"><label>47</label><mixed-citation publication-type="other" xlink:type="simple">Ross-Gillespie, A. and Kümmerli, R. (2014) Collective Decision-Making in Microbes. Frontiers in Microbiology, 5, Article No. 54. https://doi.org/10.3389/fmicb.2014.00054</mixed-citation></ref><ref id="scirp.114597-ref48"><label>48</label><mixed-citation publication-type="other" xlink:type="simple">Bhardway, N., Yan, K.K. and Gerstein, M.B. (2010) Analysis of Diverse Regulatory Networks in a Hierarchical Context Shows Consistent Tendencies for Collaboration in the Middle Levels. PNAS, 107, 6841-6846. https://doi.org/10.1073/pnas.0910867107</mixed-citation></ref><ref id="scirp.114597-ref49"><label>49</label><mixed-citation publication-type="other" xlink:type="simple">Dissado, L.A. (1990) A Fractal Interpretation of the Dielectric Response of Animal Tissues. Physics in Medicine &amp; Biology, 35, 1487-1503. https://doi.org/10.1088/0031-9155/35/11/005</mixed-citation></ref><ref id="scirp.114597-ref50"><label>50</label><mixed-citation publication-type="other" xlink:type="simple">El-Lakkani, A. (2001) Dielectric Response of Some Biological Tissues. Bioelectromagnetics, 22, 272-279. https://doi.org/10.1002/bem.50</mixed-citation></ref><ref id="scirp.114597-ref51"><label>51</label><mixed-citation publication-type="other" xlink:type="simple">Chigira, M., Noda, K. and Watanabe, H. (1990) Autonomy in Tumor Cell Proliferation. Medical Hypotheses, 32, 249-254. https://doi.org/10.1016/0306-9877(90)90101-J</mixed-citation></ref><ref id="scirp.114597-ref52"><label>52</label><mixed-citation publication-type="other" xlink:type="simple">Ngo, S., Liang, J., Su, Y.H. and O’Brien, L.E. (2020) Tumor Establishment Requires Tumor Autonomous and Non-Autonomous Deregulation of Homeostatic Feedback Control. https://doi.org/10.1101/541912</mixed-citation></ref><ref id="scirp.114597-ref53"><label>53</label><mixed-citation publication-type="other" xlink:type="simple">Li, J., Cheng, L. and Jiang, H. (2019) Cell Shape and Intercellular Adhesion Regulate Mitotic Spindle Orientation. Molecular Biology of the Cell, 30, 2458-2468. https://doi.org/10.1091/mbc.E19-04-0227</mixed-citation></ref><ref id="scirp.114597-ref54"><label>54</label><mixed-citation publication-type="other" xlink:type="simple">Szentgyorgyi, A. (1978) The Living State and Cancer. Marcel Dekker Inc., New York.</mixed-citation></ref><ref id="scirp.114597-ref55"><label>55</label><mixed-citation publication-type="other" xlink:type="simple">Jeanes, A., Gottardi, C.J. and Yap, A.S. (2008) Cadherins and Cancer: How Does Cadherin Dysfunction Promote Tumor Progression? Oncogene, 27, 6920-6929. https://doi.org/10.1038/onc.2008.343</mixed-citation></ref><ref id="scirp.114597-ref56"><label>56</label><mixed-citation publication-type="other" xlink:type="simple">Mendonsa, A.M., Na, T.Y. and Gumbiner, B.M. (2018) E-Cadherin in Contact Inhibition and Cancer. Oncogene, 37, 4769-4780. https://doi.org/10.1038/s41388-018-0304-2</mixed-citation></ref><ref id="scirp.114597-ref57"><label>57</label><mixed-citation publication-type="other" xlink:type="simple">Szasz, O., Szasz, A.M., Minnaar, C. and Szasz, A. (2017) Heating Preciosity—Trends in Modern Oncological Hyperthermia. Open Journal of Biophysics, 7, 116-144. https://doi.org/10.4236/ojbiphy.2017.73010</mixed-citation></ref><ref id="scirp.114597-ref58"><label>58</label><mixed-citation publication-type="other" xlink:type="simple">Szentgyorgyi, A. (1960) Introduction to a Submolecular Biology. Academic Press, New York. https://doi.org/10.1016/B978-0-12-395612-5.50005-1</mixed-citation></ref><ref id="scirp.114597-ref59"><label>59</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Szasz</surname><given-names> A. </given-names></name>,<etal>et al</etal>. (<year>1991</year>)<article-title>An Electrically Driven Instability: The Living-State (Does the Room Temperature Superconductivity Exist?)</article-title><source> Physiological Chemistry and Physics and Medical NMR</source><volume> 23</volume>,<fpage> 43</fpage>-<lpage>50</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.114597-ref60"><label>60</label><mixed-citation publication-type="other" xlink:type="simple">Alfarouk, K.O., Shayoub, M.E.A., Muddathir, A.K., Elhassan, G.O. and Bashir, A.H.H. (2011) Evolution of Tumour Metabolism Might Reflect Carcinogenesis as a Reverse Evolution Process (Dismantling of Multicellularity). Cancers, 3, 3002-3017. https://doi.org/10.3390/cancers3033002</mixed-citation></ref><ref id="scirp.114597-ref61"><label>61</label><mixed-citation publication-type="other" xlink:type="simple">Weinberg, R.A. (1999) One Renegade Cell. How Cancer Begins. Basic Books, New York.</mixed-citation></ref><ref id="scirp.114597-ref62"><label>62</label><mixed-citation publication-type="other" xlink:type="simple">Szigeti, Gy.P., Szasz, A.M. and Szasz, A. (2020) The Growth of Healthy and Cancerous Tissues. Open Journal of Biophysics, 10, 113-128. https://doi.org/10.4236/ojbiphy.2020.103010</mixed-citation></ref><ref id="scirp.114597-ref63"><label>63</label><mixed-citation publication-type="other" xlink:type="simple">Willmer, P. (2009) Environmental Physiology of Animals. Wiley, Hoboken.</mixed-citation></ref><ref id="scirp.114597-ref64"><label>64</label><mixed-citation publication-type="other" xlink:type="simple">West, G.B., Brown, J.H. and Enquist, B.J. (1997) A General Model for the Origin of Allometric Scaling Laws in Biology. Science, 276, 122-126. https://doi.org/10.1126/science.276.5309.122</mixed-citation></ref><ref id="scirp.114597-ref65"><label>65</label><mixed-citation publication-type="other" xlink:type="simple">Dodds, P.S., Rothman, D.H. and Weitz, J.S. (2001) Re-Examination of the “3/4-Law” of Metabolism. Journal of Theoretical Biology, 209, 9-27. https://doi.org/10.1006/jtbi.2000.2238</mixed-citation></ref><ref id="scirp.114597-ref66"><label>66</label><mixed-citation publication-type="other" xlink:type="simple">Rothman, D.H. and Weitz, J.S. (2005) Beyond the “3/4-Power Law”: Variation in the Intra- and Interspecific Scaling of Metabolic Rate in Animals. Biological Reviews, 80, 611-662. https://doi.org/10.1017/S1464793105006834</mixed-citation></ref><ref id="scirp.114597-ref67"><label>67</label><mixed-citation publication-type="other" xlink:type="simple">Kozlowski, J. and Konarzewski, M. (2004) Is West, Brown and Enquist’s Model of Allometric Scaling Mathematically Correct and Biologically Relevant? Function Ecology, 18, 283-289. https://doi.org/10.1111/j.0269-8463.2004.00830.x</mixed-citation></ref><ref id="scirp.114597-ref68"><label>68</label><mixed-citation publication-type="other" xlink:type="simple">Beckman, R.A. and Loeb, L.A. (2005) Genetic Instability in Cancer: Theory and Experiment. Seminars in Cancer Biology, 15, 423-435. https://doi.org/10.1016/j.semcancer.2005.06.007</mixed-citation></ref><ref id="scirp.114597-ref69"><label>69</label><mixed-citation publication-type="other" xlink:type="simple">Ferguson, L.R., Chen, H., Collins, A.R., Connel, M., Damia, G., Dasgupta, S., et al. (2015) Genomic Instability in Human Cancer: Molecular Insights and Opportunities for Therapeutic Attack and Prevention through Diet and Nutrition. Seminars in Cancer Biology, 35, S5-S24. https://doi.org/10.1016/j.semcancer.2015.03.005</mixed-citation></ref><ref id="scirp.114597-ref70"><label>70</label><mixed-citation publication-type="other" xlink:type="simple">Colotta, F., Allavena, P., Sica, A., Garlanda, C. and Mantovani, A. (2009) Cancer-Related Inflammation, the Seventh Hallmark of Cancer: Links to Genetic Instability. Carcinogenesis, 30, 1073-1081. https://doi.org/10.1093/carcin/bgp127</mixed-citation></ref><ref id="scirp.114597-ref71"><label>71</label><mixed-citation publication-type="other" xlink:type="simple">Luoto, K.R., Kumareswaran, R. and Bristow, R.G. (2013) Tumor Hypoxia as a Driving Force in Genetic Instability. Genome Integrity, 4, 5. https://doi.org/10.1186/2041-9414-4-5</mixed-citation></ref><ref id="scirp.114597-ref72"><label>72</label><mixed-citation publication-type="other" xlink:type="simple">Loewenstein, W.R. (1999) The Touchstone of Life, Molecular Information, Cell Communication and the Foundations of the Life. Oxford University Press, Oxford, New York, 298-304.</mixed-citation></ref><ref id="scirp.114597-ref73"><label>73</label><mixed-citation publication-type="book" xlink:type="simple">Szasz, O. (2020) Ch. 11. Local Treatment with Systemic Effect: Abscopal Outcome. In: Szasz, A., Ed., Challenges and Solutions of Oncological Hyperthermia, Cambridge Scholars Publishing, Newcastle upon Tyne District, Publishing, Newcastle upon Tyne District, 192-205.</mixed-citation></ref><ref id="scirp.114597-ref74"><label>74</label><mixed-citation publication-type="other" xlink:type="simple">Schwan, H.P. and Takashima, S. (1991) Dielectric Behavior of Biological Cells and Membranes. Bulletin of the Institute for Chemical Research, Kyoto University, 69, 459-475.</mixed-citation></ref><ref id="scirp.114597-ref75"><label>75</label><mixed-citation publication-type="other" xlink:type="simple">Cole, K.S. (1972) Membranes, Ions and Impulses. University of California Press, Berkeley.</mixed-citation></ref><ref id="scirp.114597-ref76"><label>76</label><mixed-citation publication-type="other" xlink:type="simple">Anderson, J.C. (1964) Dielectrics, Chapman &amp; Hall, London.</mixed-citation></ref><ref id="scirp.114597-ref77"><label>77</label><mixed-citation publication-type="other" xlink:type="simple">Pethig, R.R. (1979) Dielectric and Electronic Properties of Biological Materials. Wiley, Hoboken.</mixed-citation></ref><ref id="scirp.114597-ref78"><label>78</label><mixed-citation publication-type="other" xlink:type="simple">Schwan, H.P. (1957) Electrical Properties of Tissue and Cell Suspensions. Advances in Biological and Medical Physics, 5, 147. https://doi.org/10.1016/B978-1-4832-3111-2.50008-0</mixed-citation></ref><ref id="scirp.114597-ref79"><label>79</label><mixed-citation publication-type="other" xlink:type="simple">Martinsen, O.G., Grimnes, S. and Mirtaheri, P. (2000) Non-Invasive Measurements of Post Mortem Changes in Dielectric Properties of Haddock Muscle—A Pilot Study. Journal of Food Engineering, 43, 189-192. https://doi.org/10.1016/S0260-8774(99)00151-X</mixed-citation></ref><ref id="scirp.114597-ref80"><label>80</label><mixed-citation publication-type="other" xlink:type="simple">Grant, E.H., Sheppard, R.J. and South, S.P. (1978) Dielectric Behavior of Biological Molecules in Solution. Clarendon Press, Oxford.</mixed-citation></ref><ref id="scirp.114597-ref81"><label>81</label><mixed-citation publication-type="other" xlink:type="simple">Schwarz, G. and Seelig, J. (1968) Kinetic Properties and the Electric Field Effect of Life Helix-Coil Transition of Poly(y-benzyl L-glutamate) Determined from Dielectric Relaxation Measurements. Biopolymers, 6, 1263-1277. https://doi.org/10.1002/bip.1968.360060904</mixed-citation></ref><ref id="scirp.114597-ref82"><label>82</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Debye</surname><given-names> F. </given-names></name>,<etal>et al</etal>. (<year>1928</year>)<article-title>Dispersion of the Conductivity and Dielectric Constants of Strong Electrolytes</article-title><source> Physikalische Zeitschrift</source><volume> 29</volume>,<fpage> 121</fpage>-<lpage>401</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.114597-ref83"><label>83</label><mixed-citation publication-type="other" xlink:type="simple">Pennock, B.E. and Schwan, H.P. (1969) Further Observations on the Electrical Properties of Hemoglobin Bound Water. The Journal of Physical Chemistry, 73, 2600-2610. https://doi.org/10.1021/j100842a024</mixed-citation></ref><ref id="scirp.114597-ref84"><label>84</label><mixed-citation publication-type="other" xlink:type="simple">Kirkwood, J.G. and Shumaker (1952) Forces between Protein Molecules in Solution Arising from Fluctuations in Proton Charge and Configuration. Proceedings of the National Academy of Sciences of the United States of America, 38, 863-871. https://doi.org/10.1073/pnas.38.10.863</mixed-citation></ref><ref id="scirp.114597-ref85"><label>85</label><mixed-citation publication-type="other" xlink:type="simple">South, G.P. and Grant, E.H. (1972) Dielectric Dispersion and Dipole Moment of Myoglobin in Water. Proceedings of the Royal Society A, 328, 371. https://doi.org/10.1098/rspa.1972.0083</mixed-citation></ref><ref id="scirp.114597-ref86"><label>86</label><mixed-citation publication-type="other" xlink:type="simple">Pethig, R.R. (2017) Dielectrophoresis: Theory, Methodology and Biological Applications. John Wiley &amp; Sons, Hoboken. https://doi.org/10.1002/9781118671443</mixed-citation></ref><ref id="scirp.114597-ref87"><label>87</label><mixed-citation publication-type="other" xlink:type="simple">Asami, K. (2002) Characterization of Biological Cells by Dielectric Spectroscopy. Journal of Non-Crystalline Solids, 305, 268-277. https://doi.org/10.1016/S0022-3093(02)01110-9</mixed-citation></ref><ref id="scirp.114597-ref88"><label>88</label><mixed-citation publication-type="other" xlink:type="simple">Pauly, H. and Schwan, H.P. (1959) Uber die Impedanzeiner Suspension von Kugelformigen Teilchenmiteiner Schale. Zeitschrift für Naturforschung B, 14, 125-131. https://doi.org/10.1515/znb-1959-0213</mixed-citation></ref><ref id="scirp.114597-ref89"><label>89</label><mixed-citation publication-type="other" xlink:type="simple">Stoy, R.D., Foster, K.R. and Schwan, H.P. (1982) Dielectric Properties of Mammalian Tissues from 0.1 to 100 MHz: A Summary of Recent Data. Physics in Medicine &amp; Biology, 27, 501-513. https://doi.org/10.1088/0031-9155/27/4/002</mixed-citation></ref><ref id="scirp.114597-ref90"><label>90</label><mixed-citation publication-type="other" xlink:type="simple">Gotz, M., Karsch, L. and Pawelke, J. (2017) A New Model for Volume Recombination in Plane-Parallel Chambers in Pulsed Fields of High Dose-per-Pulse. Physics in Medicine &amp; Biology, 62, 8634-8654. https://doi.org/10.1088/1361-6560/aa8985</mixed-citation></ref><ref id="scirp.114597-ref91"><label>91</label><mixed-citation publication-type="other" xlink:type="simple">Pethig, R. (1984) Dielectric Properties of Biological Materials: Biophysical and Medical Application. IEEE Transactions on Electrical Insulation, E1-19, 453-474. https://doi.org/10.1109/TEI.1984.298769</mixed-citation></ref><ref id="scirp.114597-ref92"><label>92</label><mixed-citation publication-type="other" xlink:type="simple">Schwan, H.P. (1963) Determination of Biological Impedances. In: Physical Techniques in Biological Research, Vol. 6, Academic Press, New York, 323-406. https://doi.org/10.1016/B978-1-4831-6743-5.50013-7</mixed-citation></ref><ref id="scirp.114597-ref93"><label>93</label><mixed-citation publication-type="other" xlink:type="simple">Stubbe, M. and Gimsa, J. (2015) Maxwell’s Mixing Equation Revisited: Characteristic Impedance Equations for Ellipsoidal Cells. Biophysical Journal, 109, 194-208. https://doi.org/10.1016/j.bpj.2015.06.021</mixed-citation></ref><ref id="scirp.114597-ref94"><label>94</label><mixed-citation publication-type="other" xlink:type="simple">Papp, E., Vancsik, T., Kiss, E. and Szasz, O. (2017) Energy Absorption by the Membrane Rafts in the Modulated Electro-Hyperthermia (mEHT). Open Journal of Biophysics, 7, 216-229. https://doi.org/10.4236/ojbiphy.2017.74016</mixed-citation></ref><ref id="scirp.114597-ref95"><label>95</label><mixed-citation publication-type="other" xlink:type="simple">Vincze, Gy., Szigeti, Gy. andocs, G. and Szasz, A. (2015) Nanoheating without Artificial Nanoparticles. Biology and Medicine, 7, 249.</mixed-citation></ref><ref id="scirp.114597-ref96"><label>96</label><mixed-citation publication-type="other" xlink:type="simple">Megyesshazi, N. (2015) Studies on Modulated Electrohyperthermia Induced Tumor Cell Death in a Colorectal Carcinoma Model. Ph.D. Theses, Pathological Sciences Doctoral School, Semmelweis University, Budapest.</mixed-citation></ref><ref id="scirp.114597-ref97"><label>97</label><mixed-citation publication-type="other" xlink:type="simple">Waldhauer, I. and Steinle, A. (2008) NK Cells and Cancer Immunosurveillance. Oncogene, 27, 5932-5943. https://doi.org/10.1038/onc.2008.267</mixed-citation></ref><ref id="scirp.114597-ref98"><label>98</label><mixed-citation publication-type="other" xlink:type="simple">Zamai, L., Ponti, C., Mirandola, P., et al. (2007) NK Cells and Cancer. The Journal of Immunology, 178, 4011-4016. https://doi.org/10.4049/jimmunol.178.7.4011</mixed-citation></ref><ref id="scirp.114597-ref99"><label>99</label><mixed-citation publication-type="other" xlink:type="simple">Hu, W., Wang, G., Huang, D., et al. (2019) Cancer Immunotherapy Based on Natural Cell Killer Cells: Current Progress and New Opportunities. Frontiers in Immunology, 10, Article No. 1205. https://doi.org/10.3389/fimmu.2019.01205</mixed-citation></ref><ref id="scirp.114597-ref100"><label>100</label><mixed-citation publication-type="other" xlink:type="simple">Bassani, B., Baci, D. and Gallazzi, M. (2019) Natural Killer Cells as Key Players of Tumor Progression and Angiogenesis: Old and Novel Tools to Divert Their Pro-Tumor Activities into Potent Anti-Tumor Effects. Cancers, 11, 461. https://doi.org/10.3390/cancers11040461</mixed-citation></ref><ref id="scirp.114597-ref101"><label>101</label><mixed-citation publication-type="other" xlink:type="simple">Betten, A., Dahlgren, C., Mellqvist, U.H., et al. (2004) Oxygen Radical-Induced Natural Killer Cell Dysfunction: Role of Myeloperosicase and Regulation by Serotonin. Journal of Leukocyte Biology, 75, 1111-1115. https://doi.org/10.1189/jlb.1103595</mixed-citation></ref><ref id="scirp.114597-ref102"><label>102</label><mixed-citation publication-type="other" xlink:type="simple">Rosado, M.M., Simko, M., Mattsson, M.O. and Pioli, C. (2018) Immune-Modulating Perspectives for Low Frequency Electromagnetic Fields in Innate Immunity. Frontiers in Public Health, 6, Article No. 85. https://doi.org/10.3389/fpubh.2018.00085</mixed-citation></ref><ref id="scirp.114597-ref103"><label>103</label><mixed-citation publication-type="other" xlink:type="simple">Reindl, L.M., Albinger, N., Bexte, T., et al. (2020) Immunotherapy with NK Cells: Recent Developments in Gene Modification Open Up New Avenues. OncoImmunology, 9, Article ID: 1777651. https://doi.org/10.1080/2162402X.2020.1777651</mixed-citation></ref><ref id="scirp.114597-ref104"><label>104</label><mixed-citation publication-type="other" xlink:type="simple">Vancsik, T., Mathe, D., Horvath, I., et al. (2021) Modulated Electro-Hyperthermia Facilitates NK-Cell Infiltration and Growth Arrest of Human A2058 Melanoma in a Xenograft Model. Frontiers in Oncology, 11, Article ID: 590764. https://doi.org/10.3389/fonc.2021.590764</mixed-citation></ref><ref id="scirp.114597-ref105"><label>105</label><mixed-citation publication-type="other" xlink:type="simple">Damele, L., Ottonello, S., Mingari, M.C., Pietra, G. and Vitale, C. (2020) Targeted Therapies: Friends or Foes for Patient’s NK Cell-Mediated Tumor Immune-Surveillance? Cancers, 12, 774. https://doi.org/10.3390/cancers12040774</mixed-citation></ref><ref id="scirp.114597-ref106"><label>106</label><mixed-citation publication-type="other" xlink:type="simple">Meggyeshazi, N. andocs, G., Balogh, L., Balla, P., Kiszner, G., Teleki, I., Jeney, A. and Krenacs, T. (2014) DNA Fragmentation and Caspase-Independent Programmed Cell Death by Modulated Electrohyperthermia. Strahlentherapie und Onkologie, 190, 815-822. https://doi.org/10.1007/s00066-014-0617-1</mixed-citation></ref><ref id="scirp.114597-ref107"><label>107</label><mixed-citation publication-type="other" xlink:type="simple">Yang, K.L., Huang, C.C., Chi, M.S., Chiang, H.C., Wang, Y.S. andocs, G., et al. (2016) In Vitro Comparison of Conventional Hyperthermia and Modulated Electro-Hyperthermia. Oncotarget, 7, 84082-84092. https://doi.org/10.18632/oncotarget.11444</mixed-citation></ref><ref id="scirp.114597-ref108"><label>108</label><mixed-citation publication-type="other" xlink:type="simple">Andocs, G., Meggyeshazi, N., Balogh, L., Spisak, S., Maros, M.E., Balla, P., Kiszner, G., Teleki, I., Kovago, Cs. and Krenacs, T. (2014) Upregulation of Heat Shock Proteins and the Promotion of Damage-Associated Molecular Pattern Signals in a Colorectal Cancer Model by Modulated Electrohyperthermia. Cell Stress and Chaperones, 20, 37-46. https://doi.org/10.1007/s12192-014-0523-6</mixed-citation></ref><ref id="scirp.114597-ref109"><label>109</label><mixed-citation publication-type="other" xlink:type="simple">Jeon, T.W., Yang, H., Lee, C.G., et al. (2016) Electro-Hyperthermia Up-Regulates Tumour Suppressor Septin 4 to Induce Apoptotic Cell Death in Hepatocellular Carcinoma. International Journal of Hyperthermia, 7, 1-9. https://doi.org/10.1080/02656736.2016.1186290</mixed-citation></ref><ref id="scirp.114597-ref110"><label>110</label><mixed-citation publication-type="other" xlink:type="simple">Vancsik, T., Kovago, Cs., Kiss, E., et al. (2018) Modulated Electro-Hyperthermia Induced Loco-Regional and Systemic Tumor Destruction in Colorectal Cancer Allografts. Journal of Cancer, 9, 41-53. https://doi.org/10.7150/jca.21520</mixed-citation></ref><ref id="scirp.114597-ref111"><label>111</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Szasz</surname><given-names> A. </given-names></name>,<etal>et al</etal>. (<year>2019</year>)<article-title>Immune-Effects with Local Hyperthermia</article-title><source> Oncothermia Journal</source><volume> 26</volume>,<fpage> 139</fpage>-<lpage>148</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.114597-ref112"><label>112</label><mixed-citation publication-type="other" xlink:type="simple">Qin, W., Akutsu, Y. andocs, G., et al. (2014) Modulated Electro-Hyperthermia Enhances Dendritic Cell Therapy through an Abscopal Effect in Mice. Oncology Reports, 32, 2373-2379. https://doi.org/10.3892/or.2014.3500</mixed-citation></ref><ref id="scirp.114597-ref113"><label>113</label><mixed-citation publication-type="other" xlink:type="simple">Tsang, Y.W., Huang, C.C., Yang, K.L., et al. (2015) Improving Immunological Tumor Microenvironment Using Electro-Hyperthermia Followed by Dendritic Cell Immunotherapy. BMC Cancer, 15, Article No. 708. https://doi.org/10.1186/s12885-015-1690-2</mixed-citation></ref><ref id="scirp.114597-ref114"><label>114</label><mixed-citation publication-type="other" xlink:type="simple">Wust, P., Kortum, B., Strauss, U., Nadobny, J., Zschaeck, S., Beck, M., et al. (2020) Nonthermal Effects of Radiofrequency Electromagnetic Fields. Scientific Reports, 10, Article No. 13488. https://doi.org/10.1038/s41598-020-69561-3</mixed-citation></ref><ref id="scirp.114597-ref115"><label>115</label><mixed-citation publication-type="other" xlink:type="simple">Wust, P., Ghadjar, P., Nadobny, J., et al. (2019) Physical Analysis of Temperature-Dependent Effects of Amplitude-Modulated Electromagnetic Hyperthermia. International Journal of Hygiene and Environmental Health, 36, 1246-1254. https://doi.org/10.1080/02656736.2019.1692376</mixed-citation></ref><ref id="scirp.114597-ref116"><label>116</label><mixed-citation publication-type="book" xlink:type="simple">Wust, P., Nadobny, J., Zschaeck, S. and Ghadjar, P. (2020) Ch. 16. Physics of Hyperthermia—Is Physics Really against Us? In: Szasz, A., Ed., Challenges and Solutions of Oncological Hyperthermia, Cambridge Scholars Publishing, Newcastle upon Tyne District, 346-376.</mixed-citation></ref><ref id="scirp.114597-ref117"><label>117</label><mixed-citation publication-type="other" xlink:type="simple">Szasz, A. (2019) Thermal and Nonthermal Effects of Radiofrequency on Living State and Applications as an Adjuvant with Radiation Therapy. Journal of Radiation and Cancer Research, 10, 1-17. https://doi.org/10.4103/jrcr.jrcr_25_18</mixed-citation></ref><ref id="scirp.114597-ref118"><label>118</label><mixed-citation publication-type="other" xlink:type="simple">West, B.J. (1990) Fractal Physiology and Chaos in Medicine. World Scientific, Singapore, London. https://doi.org/10.1142/1025</mixed-citation></ref><ref id="scirp.114597-ref119"><label>119</label><mixed-citation publication-type="other" xlink:type="simple">Goldberger, A.L., Amaral, L.A., Hausdorff, J.M., et al. (2002) Fractal Dynamics in Physiology: Alterations with Disease and Aging. PNAS Colloquium, 99, 2466-2472. https://doi.org/10.1073/pnas.012579499</mixed-citation></ref><ref id="scirp.114597-ref120"><label>120</label><mixed-citation publication-type="other" xlink:type="simple">Stehlik, M., Hermann, P. and Nicolis, O. (2016) Fractal Based Cancer Modelling. REVSTAT—Statistical Journal, 14, 139-155.</mixed-citation></ref><ref id="scirp.114597-ref121"><label>121</label><mixed-citation publication-type="other" xlink:type="simple">Deisboeck, T.S., Guiot, C., Delsanto, P.P., et al. (2006) Does Cancer Growth Depend on Surface Extension? Medical Hypotheses, 67, 1338-1341. https://doi.org/10.1016/j.mehy.2006.05.029</mixed-citation></ref><ref id="scirp.114597-ref122"><label>122</label><mixed-citation publication-type="other" xlink:type="simple">Stehlik, M., Wartner, F. and Minarova, M. (2013) Fractal Analysis for Cancer Research: Case Study and Simulation of Fractals. Pliska Studia Mathematica Bulgarica, 22, 195-206.</mixed-citation></ref><ref id="scirp.114597-ref123"><label>123</label><mixed-citation publication-type="other" xlink:type="simple">Waliszewski, P., Molski, M. and Konarski, J. (2011) Self-Similarity, Collectivity, and Evolution of Fractal Dynamics during Retinoid-Induced Differentiation of Cancer Cell Population. Fractals, 7, 139-149. https://doi.org/10.1142/S0218348X99000165</mixed-citation></ref><ref id="scirp.114597-ref124"><label>124</label><mixed-citation publication-type="other" xlink:type="simple">Baish, J.W. and Jain, R.K. (2000) Fractals and Cancer. Cancer Research, 60, 3683-3688.</mixed-citation></ref><ref id="scirp.114597-ref125"><label>125</label><mixed-citation publication-type="other" xlink:type="simple">Liu, S., Wang, Y., Xu, K., Wang, Z., Fan, X., Zhang, C., Li, S., Qiu, X. and Jiang, T. (2017) Relationship between Necrotic Patterns in Glioblastoma and Patient Survival: Fractal Dimension and Lacunarity Analyses Using Magnetic Resonance Imaging. Scientific Reports, 7, Article No. 8302. https://doi.org/10.1038/s41598-017-08862-6</mixed-citation></ref><ref id="scirp.114597-ref126"><label>126</label><mixed-citation publication-type="other" xlink:type="simple">Szasz, A. (2021) The Capacitive Coupling Modalities for Oncological Hyperthermia. Open Journal of Biophysics, 11, 252-313. https://doi.org/10.4236/ojbiphy.2021.113010</mixed-citation></ref><ref id="scirp.114597-ref127"><label>127</label><mixed-citation publication-type="other" xlink:type="simple">Zbilut, J.P. and Marwan, N. (2008) The Wiener-Khinchin Theorem and Recurrence Quantification. Physics Letters A, 372, 6622-6626. https://doi.org/10.1016/j.physleta.2008.09.027</mixed-citation></ref><ref id="scirp.114597-ref128"><label>128</label><mixed-citation publication-type="other" xlink:type="simple">Petrova, Y.I., Schecterson, L. and Gumbiner, B.M. (2016) Roles for E-cadherin Cell Surface Regulation in Cancer. Molecular Biology of the Cell, 27, 3233-3244. https://doi.org/10.1091/mbc.E16-01-0058</mixed-citation></ref><ref id="scirp.114597-ref129"><label>129</label><mixed-citation publication-type="other" xlink:type="simple">Beavon, I.R. (2000) The E-cadherin-catenin Complex in Tumour Metastasis: Structure, Function and Regulation. European Journal of Cancer, 36, 1607-1620. https://doi.org/10.1016/S0959-8049(00)00158-1</mixed-citation></ref><ref id="scirp.114597-ref130"><label>130</label><mixed-citation publication-type="other" xlink:type="simple">Pe&amp;cacute;ina-&amp;#352;laus, N. (2003) Tumor Suppressor Gene E-cadherin and Its Role in Normal and Malignant Cells. Cancer Cell International, 3, 17. https://doi.org/10.1186/1475-2867-3-17</mixed-citation></ref><ref id="scirp.114597-ref131"><label>131</label><mixed-citation publication-type="other" xlink:type="simple">Cavallaro, U., Schaffhauser, B. and Christofori, G. (2002) Cadherins and the Tumour Progression: Is It All in a Switch? Cancer Letters, 176, 123-128. https://doi.org/10.1016/S0304-3835(01)00759-5</mixed-citation></ref><ref id="scirp.114597-ref132"><label>132</label><mixed-citation publication-type="other" xlink:type="simple">Szentgyorgyi, A. (1968) Bioelectronics: A Study on Cellular Regulations, Defence and Cancer. Academic Press, New York, London.</mixed-citation></ref><ref id="scirp.114597-ref133"><label>133</label><mixed-citation publication-type="other" xlink:type="simple">Lowenstein, W.R. and Kanno, Y. (1967) Intercellular Communication and Tissue Growth, I. Cancerous Growth. The Journal of Cell Biology, 33, 225-234. https://doi.org/10.1083/jcb.33.2.225</mixed-citation></ref><ref id="scirp.114597-ref134"><label>134</label><mixed-citation publication-type="other" xlink:type="simple">Lowenstein, W.R. and Penn, R.D. (1967) Intercellular Communication and Tissue Growth, II. Tissue Regeneration. The Journal of Cell Biology, 33, 235-242. https://doi.org/10.1083/jcb.33.2.235</mixed-citation></ref><ref id="scirp.114597-ref135"><label>135</label><mixed-citation publication-type="other" xlink:type="simple">Alimperti, S. and Andreadis, S.T. (2015) CDH2 and CDH11 Act as Regulators of Stem Cell Fate Decisions. Stem Cell Research, 14, 270-282. https://doi.org/10.1016/j.scr.2015.02.002</mixed-citation></ref><ref id="scirp.114597-ref136"><label>136</label><mixed-citation publication-type="other" xlink:type="simple">Szentgyorgyi, A. (1965) Cell Division and Cancer. Science, 149, 34-37. https://doi.org/10.1126/science.149.3679.34</mixed-citation></ref><ref id="scirp.114597-ref137"><label>137</label><mixed-citation publication-type="other" xlink:type="simple">Lugano, R., Ramachandran, M. and Dimberg, A. (2020) Tumor Angiogénesis: Causes, Consequences, Challenges and Opportunities. Cellular and Molecular Life Sciences, 77, 1745-1770. https://doi.org/10.1007/s00018-019-03351-7</mixed-citation></ref><ref id="scirp.114597-ref138"><label>138</label><mixed-citation publication-type="other" xlink:type="simple">Szasz, O. and Szasz, A. (2018) Modulated Electro-Hyperthermia, (mEHT) from LAB to Clinic. Oncothermia Journal, 23, 24-61.</mixed-citation></ref><ref id="scirp.114597-ref139"><label>139</label><mixed-citation publication-type="other" xlink:type="simple">Ritossa, F. (1962) A New Puffing Pattern Induced by Temperature Shock and DNP in Drosophila. Experimental, 18, 571-573. https://doi.org/10.1007/BF02172188</mixed-citation></ref><ref id="scirp.114597-ref140"><label>140</label><mixed-citation publication-type="other" xlink:type="simple">Csermely, P. (1998) Stress of Life from Molecules to Man. Annals of the New York Academy of Sciences, 851, 547. https://doi.org/10.1111/j.1749-6632.1998.tb08965.x</mixed-citation></ref><ref id="scirp.114597-ref141"><label>141</label><mixed-citation publication-type="other" xlink:type="simple">Soti, C. and Csermely, P. (2007) Protein Stress and Stress Proteins: Implications in Aging and Disease. Journal of Biosciences, 32, 511-515. https://doi.org/10.1007/s12038-007-0050-z</mixed-citation></ref><ref id="scirp.114597-ref142"><label>142</label><mixed-citation publication-type="other" xlink:type="simple">Vega, V.L., Rodriguez, Silva, M., Frey, T., Gehrmann, M., Diaz, J.C., et al. (2008) Hsp70 Translocates into the Plasma Membrane after Stress and Is Released into the Extracellular Environment in a Membrane-Associated form That Activates Macrophages. The Journal of Immunology, 180, 4299-4307. https://doi.org/10.4049/jimmunol.180.6.4299</mixed-citation></ref><ref id="scirp.114597-ref143"><label>143</label><mixed-citation publication-type="other" xlink:type="simple">Juhasz, K., Lipp, A.M., Nimmervoll, B., Sonnleitner, A., et al. (2013) The Complex Function of Hsp70 in Metastatic Cancer. Cancers, 6, 42-66. https://doi.org/10.3390/cancers6010042</mixed-citation></ref><ref id="scirp.114597-ref144"><label>144</label><mixed-citation publication-type="other" xlink:type="simple">Ohtsuka, K., Kawashima, D. and Asai, M. (2007) Dual Functions of Heat Shock Proteins: Molecular Chaperones Inside of Cells and Danger Signals Outside of Cells. Thermal Medicine, 23, 11-22. https://doi.org/10.3191/thermalmedicine.23.11</mixed-citation></ref><ref id="scirp.114597-ref145"><label>145</label><mixed-citation publication-type="other" xlink:type="simple">Soti, Cs., Nagy, E., Giricz, Z., Vigh, L., Csermely, P. and Ferdinandy, P. (2005) Heat Shock Proteins as Emerging Therapeutic Targets. British Journal of Pharmacology, 146, 679-780. https://doi.org/10.1038/sj.bjp.0706396</mixed-citation></ref><ref id="scirp.114597-ref146"><label>146</label><mixed-citation publication-type="other" xlink:type="simple">Torok, Z.S., Crul, T., Maresca, B., Schutz, G.J., Viana, F., et al. (2014) Plasma Membranes as Heat Stress Sensors: From Lipid-Controlled Molecular Switches to Therapeutic Applications. Biochimica et Biophysica Acta, 1838, 1594-1618. https://doi.org/10.1016/j.bbamem.2013.12.015</mixed-citation></ref><ref id="scirp.114597-ref147"><label>147</label><mixed-citation publication-type="other" xlink:type="simple">Shevtsov, M., Balogi, Z.S., Khachatryan, W., Gao, H., Vigh, L. and Multhof, F.G. (2020) Membrane-Associated Heat Shock Proteins in Oncology: From Basic Research to New Theranostic Targets. Cells, 9, 1263. https://doi.org/10.3390/cells9051263</mixed-citation></ref><ref id="scirp.114597-ref148"><label>148</label><mixed-citation publication-type="other" xlink:type="simple">Andocs, G., Rehman, M.U., Zhao, Q.L., Papp, E., Kondo, T. and Szasz, A. (2015) Nanoheating without Artificial Nanoparticles Part II. Experimental Support of the Nanoheating Concept of the Modulated Electro-Hyperthermia Method, Using U937 Cell Suspension Model. Biology and Medicine, 7, 1-9. https://doi.org/10.4172/0974-8369.1000247</mixed-citation></ref><ref id="scirp.114597-ref149"><label>149</label><mixed-citation publication-type="other" xlink:type="simple">Danics, L., Schvarcz, Cs., Viana, P., et al. (2020) Exhaustion of Protective Heat Shock Response Induces Significant Tumor Damage by Apoptosis after Modulated Electro-Hyperthermia Treatment of Triple Negative Breast Cancer Isografts in Mice. Cancers, 12, 2581. https://doi.org/10.3390/cancers12092581</mixed-citation></ref><ref id="scirp.114597-ref150"><label>150</label><mixed-citation publication-type="other" xlink:type="simple">Wang, X.Y., Li, Y., Yang, G. and Subjeck, J.R. (2005) Current Ideas about Applications of Heat Shock Proteins in Vaccine Design and Immunotherapy. International Journal of Hyperthermia, 21, 717-722. https://doi.org/10.1080/02656730500226407</mixed-citation></ref><ref id="scirp.114597-ref151"><label>151</label><mixed-citation publication-type="other" xlink:type="simple">Calderwood, S.K., Mambula, S.S. and Gray Jr., P.J. (2007) Extracellular Heat Shock Proteins in Cell Signalling and Immunity. Annals of the New York Academy of Sciences, 1113, 28-39. https://doi.org/10.1196/annals.1391.019</mixed-citation></ref><ref id="scirp.114597-ref152"><label>152</label><mixed-citation publication-type="other" xlink:type="simple">Pederson, T. (2003) Historical Review: An Energy Reservoir for Mitosis, and Its Productive Wake. Trends in Biochemical Sciences, 28, 125-129. https://doi.org/10.1016/S0968-0004(03)00030-6</mixed-citation></ref><ref id="scirp.114597-ref153"><label>153</label><mixed-citation publication-type="other" xlink:type="simple">Warburg, O. (1996) Oxygen, The Creator of Differentiation, Biochemical Energetics. Academic Press, New York.</mixed-citation></ref><ref id="scirp.114597-ref154"><label>154</label><mixed-citation publication-type="other" xlink:type="simple">Szentgyorgyi, A. (1998) Electronic Biology and Cancer. Marcel Dekker, New York.</mixed-citation></ref><ref id="scirp.114597-ref155"><label>155</label><mixed-citation publication-type="other" xlink:type="simple">Sengupta, A., Gupta, S., Sharda, A., et al. (2021) Effect of Low Frequency Electrical Current on the Biophysical and Molecular Properties of Cancer Cells. International Journal of Cancer and Clinical Research, 8, 145. https://doi.org/10.23937/2378-3419/1410145</mixed-citation></ref><ref id="scirp.114597-ref156"><label>156</label><mixed-citation publication-type="other" xlink:type="simple">Lanouette, W. and Silard, B. (1992) Genius in the Shadows. Macmillan Publishing Co., New York.</mixed-citation></ref><ref id="scirp.114597-ref157"><label>157</label><mixed-citation publication-type="other" xlink:type="simple">Meng, X. and Riordan, N.H. (2006) Cancer Is a Functional Repair Tissue. Medical Hypotheses, 66, 486-490. https://doi.org/10.1016/j.mehy.2005.09.041</mixed-citation></ref><ref id="scirp.114597-ref158"><label>158</label><mixed-citation publication-type="other" xlink:type="simple">McCarthy-Morrogh, L. and Martin, P. (2020) The Hallmarks of Cancer Are Also Hallmarks of Wound Healing. Science Signaling, 13, eaay8690. https://doi.org/10.1126/scisignal.aay8690</mixed-citation></ref><ref id="scirp.114597-ref159"><label>159</label><mixed-citation publication-type="other" xlink:type="simple">Deyell, M., Garris C.S. and Laughney, A.M. (2021) Cancer Metastasis as a Non-Healing Wound. British Journal of Cancer, 124, 1491-1502. https://doi.org/10.1038/s41416-021-01309-w</mixed-citation></ref><ref id="scirp.114597-ref160"><label>160</label><mixed-citation publication-type="other" xlink:type="simple">Sundaram, G.M., Quah, S. and Sampath, P. (2018) Cancer: The Dark Side of Wound Healing. The FEBS Journal, 285, 4516-4534. https://doi.org/10.1111/febs.14586</mixed-citation></ref><ref id="scirp.114597-ref161"><label>161</label><mixed-citation publication-type="other" xlink:type="simple">Shin, B.J. and Ching, S.S. (2003) A Case of Limbal Stem Cell Deficiency in a Patient with Chronic Mucocutaneous Candiddiasis. Investigative Ophthalmology &amp; Visual Science, 44, 1359.</mixed-citation></ref><ref id="scirp.114597-ref162"><label>162</label><mixed-citation publication-type="other" xlink:type="simple">Houghton, J., Stoicov, C., Nomura, S., et al. (2004) Gastric Cancer Originating from Bone Marrow-Derived Cells. Science, 306, 1568-1571. https://doi.org/10.1126/science.1099513</mixed-citation></ref><ref id="scirp.114597-ref163"><label>163</label><mixed-citation publication-type="other" xlink:type="simple">Ouahes, N., Phillips, T.J. and Park, H.Y. (1998) Expression of c-fos and c-Ha-ras Protooncogenes Is Induced in Human Chronic Wounds. Dermatologic Surgery, 24, 1354-1357. https://doi.org/10.1111/j.1524-4725.1998.tb00014.x</mixed-citation></ref><ref id="scirp.114597-ref164"><label>164</label><mixed-citation publication-type="other" xlink:type="simple">Huang, S., Trujillo, J.M. and Chakrabarty, S. (1992) Proliferation of Human Colon Cancer Cells: Role of Epidermal Growth Factor and Transforming Growth Factor. International Journal of Cancer, 52, 978-986. https://doi.org/10.1002/ijc.2910520625</mixed-citation></ref><ref id="scirp.114597-ref165"><label>165</label><mixed-citation publication-type="other" xlink:type="simple">Dahiya, R., Lee, C., Haughney, P.C., et al. (1996) Differential Gene Expression of Transforming Growth Factors Alpha and Beta, Epidermal Growth Factor, Keratinocyte Growth Factor, and Their Receptors in Fetal and Adult Human Prostatic Tissues and Cancer Cell Lines. Urology, 48, 963-970. https://doi.org/10.1016/S0090-4295(96)00376-7</mixed-citation></ref><ref id="scirp.114597-ref166"><label>166</label><mixed-citation publication-type="other" xlink:type="simple">Mizuno, K., Sone, S., Orino, E., et al. (1994) Autonomous Expressions of Cytokine Genes by Human Lung Cancer Cells and Their Paracrine Regulation. Japanese Journal of Cancer and Oncology Research, 85, 179-186. https://doi.org/10.1111/j.1349-7006.1994.tb02080.x</mixed-citation></ref><ref id="scirp.114597-ref167"><label>167</label><mixed-citation publication-type="other" xlink:type="simple">Zhang, H., Vutskits, L., Pepper, M.S., et al. (2003) VEGF Is a Chemoattractant for FGF-2-Stimulated Neural Progenitors. Journal of Cell Biology, 163, 1375-1384. https://doi.org/10.1083/jcb.200308040</mixed-citation></ref><ref id="scirp.114597-ref168"><label>168</label><mixed-citation publication-type="other" xlink:type="simple">Cicuttini, F.M., Begley, C.G. and Boyd, A.W. (1992) The Effect of Recombinant Stem Cell Factor (SCF) on Purified CD34-Positive Human Umbilical Cord Blood Progenitor Cells. Growth Factors, 6, 31-39. https://doi.org/10.3109/08977199209008869</mixed-citation></ref><ref id="scirp.114597-ref169"><label>169</label><mixed-citation publication-type="other" xlink:type="simple">Lovelady, D.C., Richmond, T.C., Maggi, A.N., Lo, C.M. and Rabson, D.A. (2007) Distinguishing Cancerous from Non-Cancerous Cells through Analysis of Electrical Noise. Physical Review E, 76, Article ID: 041908. https://doi.org/10.1103/PhysRevE.76.041908</mixed-citation></ref><ref id="scirp.114597-ref170"><label>170</label><mixed-citation publication-type="other" xlink:type="simple">Lovelady, D.C., Friedman, J., Patel, S., et al. (2009) Detecting Effects of Low Levels of Cytochalasin B in 3T3 Fibroblast Cultures by Analysis of Electrical Noise Obtained from Cellular Micromotion. Biosensors and Bioelectronics, 24, 2250-2254. https://doi.org/10.1016/j.bios.2008.09.033</mixed-citation></ref><ref id="scirp.114597-ref171"><label>171</label><mixed-citation publication-type="other" xlink:type="simple">Lineweaver, C.H., Davies, P.C.W. and Vincent, M.D. (2014) Targeting Cancer’s Weaknesses (Not Its Strengths): Therapeutic Strategies Suggested by the Atavistic Model. Bioessays, 36, 827-835. https://doi.org/10.1002/bies.201400070</mixed-citation></ref><ref id="scirp.114597-ref172"><label>172</label><mixed-citation publication-type="other" xlink:type="simple">Jezequel, P. and Campone, M. (2018) Comment on “How the Evolution of Multicellularity Set the Stage for Cancer”. British Journal of Cancer, 119, 133-134. https://doi.org/10.1038/s41416-018-0091-0</mixed-citation></ref><ref id="scirp.114597-ref173"><label>173</label><mixed-citation publication-type="other" xlink:type="simple">Andocs, G., Szasz, O. and Szasz, A. (2009) Oncothermia Treatment of Cancer: From the Laboratory to Clinic. Electromagnetic Biology and Medicine, 28, 148-165. https://doi.org/10.1080/15368370902724633</mixed-citation></ref><ref id="scirp.114597-ref174"><label>174</label><mixed-citation publication-type="other" xlink:type="simple">Wust, P., Ghadjar, P., Nadobny, J. and Beck, M. (2019) Physical Potentials of Radiofrequency Hyperthermia with Amplitude Modulation. Oncothermia Journal, 26, 128-137.</mixed-citation></ref><ref id="scirp.114597-ref175"><label>175</label><mixed-citation publication-type="other" xlink:type="simple">Vincze, Gy. and Szasz, A. (2018) Similarities of Modulation by Temperature and by Electric Field. Ojbiphy, 8, 95-103. https://doi.org/10.4236/ojbiphy.2018.83008</mixed-citation></ref><ref id="scirp.114597-ref176"><label>176</label><mixed-citation publication-type="other" xlink:type="simple">Andocs, G., Renner, H., Balogh, L., Fonyad, L., Jakab, C. and Szasz, A. (2009) Strong Synergy of Heat and Modulated Electro-Magnetic Field in Tumor Cell Killing, Study of HT29 Xenograft Tumors in a Nude Mice Model. Strahlentherapie und Onkologie, 185, 120-126. https://doi.org/10.1007/s00066-009-1903-1</mixed-citation></ref><ref id="scirp.114597-ref177"><label>177</label><mixed-citation publication-type="other" xlink:type="simple">Nagy, G., Meggyeshazi, N. and Szasz, O. (2013) Deep Temperature Measurements in Oncothermia Processes. Conference Papers in Medicine, 2013, Article ID: 685264. https://doi.org/10.1155/2013/685264</mixed-citation></ref><ref id="scirp.114597-ref178"><label>178</label><mixed-citation publication-type="other" xlink:type="simple">Hossain, M.T., Prasad, B., Park, K.S., et al. (2016) Simulation and Experimental Evaluation of Selective Heating Characteristics of 13, 56 MHz Radiofrequency Hyperthermia in Phantom Models. International Journal of Precision Engineering and Manufacturing, 17, 253-256. https://doi.org/10.1007/s12541-016-0033-9</mixed-citation></ref><ref id="scirp.114597-ref179"><label>179</label><mixed-citation publication-type="book" xlink:type="simple">Orczy-Timko, B. (2020) Ch. 18. Phantom Measurements with the EHY-2030 Device. In: Szasz, A., Ed., Challenges and Solutions of Oncological Hyperthermia, Cambridge Scholars Publishing, Newcastle upon Tyne District, 416-428.</mixed-citation></ref><ref id="scirp.114597-ref180"><label>180</label><mixed-citation publication-type="other" xlink:type="simple">Szasz, O. and Szasz, A. (2021) Approaching Complexity: Hyperthermia Dose and Its Possible Measurement in Oncology. Ojbiphy, 11, 68-132. https://doi.org/10.4236/ojbiphy.2021.111002</mixed-citation></ref><ref id="scirp.114597-ref181"><label>181</label><mixed-citation publication-type="other" xlink:type="simple">Szasz, A. and Vincze, Gy. (2006) Dose Concept of Oncological Hyperthermia: Heat-Equation Considering the Cell Destruction. Journal of Cancer Research and Therapeutics, 2, 171-181. https://doi.org/10.4103/0973-1482.29827</mixed-citation></ref><ref id="scirp.114597-ref182"><label>182</label><mixed-citation publication-type="other" xlink:type="simple">Lee, S.Y., Szigeti, G.P. and Szasz, A.M. (2019) Oncological Hyperthermia: The Correct Dosing in Clinical Applications. International Journal of Oncology, 54, 627-643. https://doi.org/10.3892/ijo.2018.4645</mixed-citation></ref><ref id="scirp.114597-ref183"><label>183</label><mixed-citation publication-type="other" xlink:type="simple">Szasz, A., Vincze, Gy., Szasz, O. and Szasz, N. (2003) An Energy Analysis of Extracellular Hyperthermia. Magneto- and Electro-Biology, 22, 103-115. https://doi.org/10.1081/JBC-120024620</mixed-citation></ref><ref id="scirp.114597-ref184"><label>184</label><mixed-citation publication-type="other" xlink:type="simple">Vincze, Gy. and Szasz, A. (2015) Effect of Cellular Membrane Resistivity Inhomogeneity on the Thermal Noise-Limit. Journal of Advances in Physics, 11, 3170-3183. https://doi.org/10.24297/jap.v11i3.6859</mixed-citation></ref><ref id="scirp.114597-ref185"><label>185</label><mixed-citation publication-type="other" xlink:type="simple">Vincze, Gy. and Szasz, A. (2015) Reorganization of Actin Filaments and Microtubules by Outside Electric Field. Journal of Advances in Biology, 8, 1514-1518.</mixed-citation></ref><ref id="scirp.114597-ref186"><label>186</label><mixed-citation publication-type="other" xlink:type="simple">Lee, S.Y., Fiorentini, G., Szasz, A.M., Szigeti, Gy., Szasz, A. and Minnaar, C.A. (2020) Quo Vadis Oncological Hyperthermia (2020)? Frontiers in Oncology, 10, Article No. 1690. https://doi.org/10.3389/fonc.2020.01690</mixed-citation></ref><ref id="scirp.114597-ref187"><label>187</label><mixed-citation publication-type="other" xlink:type="simple">Szasz, O. and Szasz, A. (2014) Oncothermia—Nano-Heating Paradigm. Journal of Cancer Science and Therapy, 6, 4. https://doi.org/10.4172/1948-5956.1000259</mixed-citation></ref><ref id="scirp.114597-ref188"><label>188</label><mixed-citation publication-type="book" xlink:type="simple">Szasz, A. (2013) Chapter 4. Electromagnetic Effects in Nanoscale Range. In: Shimizu, T. and Kondo, T., Eds., Cellular Response to Physical Stress and Therapeutic Applications, Nova Science Publishers, Hauppauge, 55-81.</mixed-citation></ref><ref id="scirp.114597-ref189"><label>189</label><mixed-citation publication-type="other" xlink:type="simple">Andocs, G., Rehman, M.U., Zhao, Q.L., Tabuchi, Y., Kanamori, M. and Kondo, T. (2016) Comparison of Biological Effects of Modulated Electro-Hyperthermia and Conventional Heat Treatment in Human Lymphoma U937 Cell. Cell Death Discovery, 2, 16039. https://doi.org/10.1038/cddiscovery.2016.39</mixed-citation></ref><ref id="scirp.114597-ref190"><label>190</label><mixed-citation publication-type="other" xlink:type="simple">Szasz, A. (2020) Towards the Immunogenic Hyperthermic Action: Modulated Electro-Hyperthermia. Clinical Oncology and Research, Science Repository, 3, 5-6. https://doi.org/10.31487/j.COR.2020.09.07</mixed-citation></ref><ref id="scirp.114597-ref191"><label>191</label><mixed-citation publication-type="other" xlink:type="simple">Kim, J.K., Prasad, B. and Kim, S. (2017) Temperature Mapping and Thermal Dose Calculation in Combined Radiation Therapy and 13.56 MHz Radiofrequency Hyperthermia for Tumor Treatment. Proceedings SPIE 10047, Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XXVI, Volume 10047, Article ID: 1004718. https://doi.org/10.1117/12.2253163</mixed-citation></ref><ref id="scirp.114597-ref192"><label>192</label><mixed-citation publication-type="other" xlink:type="simple">Prasad, B., Kim, S., Cho, W., et al. (2019) Quantitative Estimation of the Equivalent Radiation Dose Escalation Using Radiofrequency Hyperthermia in Mouse Xenograft Models of Human Lung Cancer. Scientific Reports, 9, Article No. 3942. https://doi.org/10.1038/s41598-019-40595-6</mixed-citation></ref><ref id="scirp.114597-ref193"><label>193</label><mixed-citation publication-type="other" xlink:type="simple">Forika, G., Balogh, A., Vancsik, T., Zalatnai, A., et al. (2020) Modulated Electro-Hyperthermia Resolves Radioresistance of Panc1 Pancreas Adenocarcinoma and Promotes DNA Damage and Apoptosis in Vitro. International Journal of Molecular Sciences, 21, 5100. https://doi.org/10.3390/ijms21145100</mixed-citation></ref><ref id="scirp.114597-ref194"><label>194</label><mixed-citation publication-type="other" xlink:type="simple">Vancsik, T., Forika, G., Balogh, A., et al. (2019) Modulated Electro-Hyperthermia Induced p53 Driven Apoptosis and Cell Cycle Arrest Additively Support Doxorubicin Chemotherapy of Colorectal Cancer in Vitro. Cancer Medicine, 8, 4292-4303. https://doi.org/10.1002/cam4.2330</mixed-citation></ref><ref id="scirp.114597-ref195"><label>195</label><mixed-citation publication-type="other" xlink:type="simple">Tsang, Y.W., Chi, K.H., Huang, C.C., et al. (2019) Modulated Electro-Hyperthermia-Enhanced Liposomal Drug Uptake by Cancer Cells. International Journal of Nanomedicine, 14, 1269-1579. https://doi.org/10.2147/IJN.S188791</mixed-citation></ref><ref id="scirp.114597-ref196"><label>196</label><mixed-citation publication-type="other" xlink:type="simple">Krenacs, T., Meggyeshazi, N., Forika, G., et al. (2020) Modulated Electro-Hyperthermia-Induced Tumor Damage Mechanisms Revealed in Cancer Models. International Journal of Molecular Sciences, 21, 6270. https://doi.org/10.3390/ijms21176270</mixed-citation></ref><ref id="scirp.114597-ref197"><label>197</label><mixed-citation publication-type="other" xlink:type="simple">Wismeth, C., Dudel, C., Pascher, C., et al. (2010) Transcranial Electro-Hyperthermia Combined with Alkylating Chemotherapy in Patients with Relapsed High-Grade Gliomas—Phase I Clinical Results. Journal of Neuro-Oncology, 98, 395-405. https://doi.org/10.1007/s11060-009-0093-0</mixed-citation></ref><ref id="scirp.114597-ref198"><label>198</label><mixed-citation publication-type="other" xlink:type="simple">Sahinbas, H., Groenemeyer, D.H.W., Boecher, E. and Szasz, A. (2007) Retrospective Clinical Study of Adjuvant Electro-Hyperthermia Treatment for Advanced Brain-Gliomas. Deutsche Zeitschriftfuer Onkologie, 39, 154-160. https://doi.org/10.1055/s-2007-986020</mixed-citation></ref><ref id="scirp.114597-ref199"><label>199</label><mixed-citation publication-type="other" xlink:type="simple">Fiorentini, G., Sarti, D., Milandri, C., et al. (2018) Modulated Electrohyperthermia in Integrative Cancer Treatment for Relapsed Malignant Glioblastoma and Astrocytoma: Retrospective Multicenter Controlled Study. Integrative Cancer Therapies, 18, 1-11. https://doi.org/10.1177/1534735418812691</mixed-citation></ref><ref id="scirp.114597-ref200"><label>200</label><mixed-citation publication-type="book" xlink:type="simple">Fiorentini, G., Sarti, D., Casadei, V., et al. (2020) Ch. 6. Modulated Electro-Hyperthermia for the Treatment of Relapsed Brain Gliomas. In: Szasz, A., Ed., Challenges and Solutions of Oncological Hyperthermia, Cambridge Scholars Publishing, Newcastle upon Tyne District, 110-125.</mixed-citation></ref><ref id="scirp.114597-ref201"><label>201</label><mixed-citation publication-type="other" xlink:type="simple">Ou, J., Zhu, X., Lu, Y., et al. (2017) The Safety and Pharmacokinetics of High Dose Intravenous Ascorbic Acid Synergy with Modulated Electrohyperthermia in Chinese Patients with Stage III-IV Non-Small Cell Lung Cancer. European Journal of Pharmaceutical Sciences, 109, 412-418. https://doi.org/10.1016/j.ejps.2017.08.011</mixed-citation></ref><ref id="scirp.114597-ref202"><label>202</label><mixed-citation publication-type="other" xlink:type="simple">Ou, J., Zhu, X., Chen, P., et al. (2020) A Randomized Phase II Trial of Best Supportive Care with or without Hyperthermia and Vitamin C for Heavily Pretreated, Advanced, Refractory Non-Small-Cell Lung Cancer. Journal of Advanced Research, 24, 175-182. https://doi.org/10.1016/j.jare.2020.03.004</mixed-citation></ref><ref id="scirp.114597-ref203"><label>203</label><mixed-citation publication-type="other" xlink:type="simple">Roussakow, S. (2017) Clinical and Economic Evaluation of Modulated Electrohyperthermia Concurrent to Dose-Dense Temozolomide 21/28 Days Regimen in the Treatment of Recurrent Glioblastoma: A Retrospective Analysis of a Two-Centre German Cohort Trial with Systematic Comparison and Effect-to-Treatment Analysis. BMJ Open, 7, e017387. https://doi.org/10.1136/bmjopen-2017-017387</mixed-citation></ref><ref id="scirp.114597-ref204"><label>204</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Roussakow</surname><given-names> S.V. </given-names></name>,<etal>et al</etal>. (<year>2016</year>)<article-title>Pharmacoeconomic Study of Oncothermia (Modulated Electro-Hyperthermia) in the Treatment of Lung Cancer</article-title><source> Oncothermia Journal</source><volume> 18</volume>,<fpage> 116</fpage>-<lpage>138</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.114597-ref205"><label>205</label><mixed-citation publication-type="other" xlink:type="simple">Ranieri, G., Laface, C., Laforgia, M., et al. (2020) Bevacizumab plus FOLFOX-4 Combined with Deep Electro-Hyperthermia as First-Line Therapy in Metastatic Colon Cancer: A Pilot Study. Frontiers in Oncology, 10, Article ID: 590707. https://doi.org/10.3389/fonc.2020.590707</mixed-citation></ref><ref id="scirp.114597-ref206"><label>206</label><mixed-citation publication-type="other" xlink:type="simple">Kim, S., Lee, J.H., Cha, J. and You, S.H. (2021) Beneficial Effects of Modulated Electro-Hyperthermia during Neoadjuvant Treatment for Locally Advanced Rectal Cancer. International Journal of Hyperthermia, 38, 144-151. https://doi.org/10.1080/02656736.2021.1877837</mixed-citation></ref><ref id="scirp.114597-ref207"><label>207</label><mixed-citation publication-type="other" xlink:type="simple">Gadaleta-Caldarola, G., Infusino, S., Galise, I., et al. (2014) Sorafenib and Locoregional Deep Electro-Hyperthermia in Advanced Hepatocellular Carcinoma. A Phase II Study. Oncology Letters, 8, 1783-1787. https://doi.org/10.3892/ol.2014.2376</mixed-citation></ref><ref id="scirp.114597-ref208"><label>208</label><mixed-citation publication-type="other" xlink:type="simple">Fiorentini, G., Sarti, D., Casadei, V., et al. (2019) Modulated Electro-Hyperthermia as Palliative Treatment for Pancreas Cancer: A Retrospective Observational Study on 106 Patients. Integrative Cancer Therapies, 18, 1-8. https://doi.org/10.1177/1534735419878505</mixed-citation></ref><ref id="scirp.114597-ref209"><label>209</label><mixed-citation publication-type="other" xlink:type="simple">Volovat, C., Volovat, S.R., Scripcaru, V., et al. (2014) Second-Line Chemotherapy with Gemcitabine and Oxaliplatin in Combination with Loco-Regional Hyperthermia (EHY-2000) in Patients with Refractory Metastatic Pancreatic Cancer—Preliminary Results of a Prospective Trial. Romanian Reports in Physics, 66, 166-174.</mixed-citation></ref><ref id="scirp.114597-ref210"><label>210</label><mixed-citation publication-type="other" xlink:type="simple">Yoo, H.J., Lim, M.C., Seo, S.S., et al. (2019) Phase I/II Clinical Trial of Modulated Electro-Hyperthermia Treatment in Patients with Relapsed, Refractory or Progressive Heavily Treated Ovarian Cancer. Japanese Journal of Clinical Oncology, 49, 832-838. https://doi.org/10.1093/jjco/hyz071</mixed-citation></ref><ref id="scirp.114597-ref211"><label>211</label><mixed-citation publication-type="other" xlink:type="simple">Lee, S.Y., Lee, N.R., Cho, D.H., et al. (2017) Treatment Outcome Analysis of Chemotherapy Combined with Modulated Electro-Hyperthermia Compared with Chemotherapy Alone for Recurrent Cervical Cancer, Following Irradiation. Oncology Letters, 14, 73-78. https://doi.org/10.3892/ol.2017.6117</mixed-citation></ref><ref id="scirp.114597-ref212"><label>212</label><mixed-citation publication-type="other" xlink:type="simple">Minnaar, C.A., Kotzen, J.A., Ayeni, O.A., et al. (2019) The Effect of Modulated Electro-Hyperthermia on Local Disease Control in HIV-Positive and -Negative Cervical Cancer Women in South Africa: Early Results from a Phase III Randomized Controlled Trial. PLoS ONE, 14, e0217894. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6584021 https://doi.org/10.1371/journal.pone.0217894</mixed-citation></ref><ref id="scirp.114597-ref213"><label>213</label><mixed-citation publication-type="other" xlink:type="simple">Minnaar, C.A., Kotzen, J.A., Naidoo, T., et al. (2020) Analysis of the Effects of mEHT on the Treatment-Related Toxicity and Quality of Life of HIV-Positive Cervical Cancer Patients. International Journal of Hyperthermia, 37, 263-272. https://doi.org/10.1080/02656736.2020.1737253</mixed-citation></ref><ref id="scirp.114597-ref214"><label>214</label><mixed-citation publication-type="other" xlink:type="simple">Jeung, T.S., Ma, S.Y., Choi, J., et al. (2015) Results of Oncothermia Combined with Operation, Chemotherapy and Radiation Therapy for Primary, Recurrent and Metastatic Sarcoma. Case Reports in Clinical Medicine, 4, 157-168. https://doi.org/10.4236/crcm.2015.45033</mixed-citation></ref><ref id="scirp.114597-ref215"><label>215</label><mixed-citation publication-type="other" xlink:type="simple">Volovat, C., Volovat, S.R., Scripcaru, V., et al. (2014) The Results of Combination of Ifosfamid and Locoregional Hyperthermia (EHY 2000) in Patients with Advanced Abdominal Soft-Tissue Sarcoma after Relapse of First Line Chemotherapy. Romanian Reports in Physics, 66, 175-181.</mixed-citation></ref><ref id="scirp.114597-ref216"><label>216</label><mixed-citation publication-type="other" xlink:type="simple">Van, Gool, S.W., Makalowski, J., Feyen, O., Prix, L., Schirrmacher, V. and Stuecker, W. (2018) The Induction of Immunogenic Cell Death (ICD) during Maintenance Chemotherapy and Subsequent Multimodal Immunotherapy for Glioblastoma (GBM). Austin Oncology Case Reports, 3, 1010.</mixed-citation></ref><ref id="scirp.114597-ref217"><label>217</label><mixed-citation publication-type="other" xlink:type="simple">Chi, M.S., Mehta, M.P., Yang, K.L., et al. (2020) Putative Abscopal Effect in Three Patients Treated by Combined Radiotherapy and Modulated Electrohyperthermia. Frontiers in Oncology, 10, Article No. 254. https://doi.org/10.3389/fonc.2020.00254</mixed-citation></ref><ref id="scirp.114597-ref218"><label>218</label><mixed-citation publication-type="other" xlink:type="simple">Minnaar, C.A., Kotzen, J.A., Ayeni, O.A., et al. (2020) Potentiation of the Abscopal Effect by Modulated Electro-Hyperthermia in Locally Advanced Cervical Cancer Patients. Frontiers in Oncology, 10, Article No. 376. https://doi.org/10.3389/fonc.2020.00376</mixed-citation></ref><ref id="scirp.114597-ref219"><label>219</label><mixed-citation publication-type="book" xlink:type="simple">Chi, K.H. (2020) Ch. 12. Tumour-Directed Immunotherapy: Clinical Results of Radiotherapy with Modulated Electro-Hyperthermia. In: Szasz, A., Ed., Challenges and Solutions of Oncological Hyperthermia, Cambridge Scholars Publishing, Newcastle upon Tyne District, 206-226.https://www.cambridgescholars.com/challenges-and-solutions-of-oncological-hyperthermia</mixed-citation></ref><ref id="scirp.114597-ref220"><label>220</label><mixed-citation publication-type="book" xlink:type="simple">Van, Gool, S.W., Makalowski, J., Domogalla, M.P., et al. (2020) Ch. 7. Personalised Medicine in Glioblastoma Multiforme. In: Szasz, A., Ed., Challenges and Solutions of Oncological Hyperthermia, Cambridge Scholars Publishing, Newcastle upon Tyne District, 126-158.</mixed-citation></ref><ref id="scirp.114597-ref221"><label>221</label><mixed-citation publication-type="other" xlink:type="simple">Pang, C.L.K., Zhang, X., Wang, Z., et al. (2017) Local Modulated Electro-Hyper-thermia in Combination with Traditional Chinese Medicine vs. Intraperitoneal Chemoinfusion for the Treatment of Peritoneal Carcinomatosis with Malignant Ascites: A Phase II Randomized Trial. Molecular and Clinical Oncology, 6, 723-732. https://doi.org/10.3892/mco.2017.1221</mixed-citation></ref><ref id="scirp.114597-ref222"><label>222</label><mixed-citation publication-type="other" xlink:type="simple">Szasz, A.M., Minnaar, C.A., Szentmartoni, Gy., et al. (2019) Review of the Clinical Evidences of Modulated Electro-Hyperthermia (mEHT) Method: An Update for the Practicing Oncologist. Frontiers in Oncology, 9, Article No. 1012. https://doi.org/10.3389/fonc.2019.01012</mixed-citation></ref><ref id="scirp.114597-ref223"><label>223</label><mixed-citation publication-type="book" xlink:type="simple">Szasz, A.M., Arkosy, P., Arrojo, E.E., et al. (2020) Ch. 2. Guidelines for Local Hyperthermia Treatment in Oncology. In: Szasz, A., Ed., Challenges and Solutions of Oncological Hyperthermia, Cambridge Scholars Publishing, Newcastle upon Tyne District, 32-71.</mixed-citation></ref><ref id="scirp.114597-ref224"><label>224</label><mixed-citation publication-type="other" xlink:type="simple">Van, Gool, S.W., Makalowski, J., Fiore, S., et al. (2021) Randomized Controlled Immunotherapy Clinical Trials for GBM Challenged. Cancers, 13, 32. https://doi.org/10.3390/cancers13010032</mixed-citation></ref><ref id="scirp.114597-ref225"><label>225</label><mixed-citation publication-type="other" xlink:type="simple">Szasz, A., Szasz, N. and Szasz, O. (2010) Oncothermia—Principles and Practices. Springer Science, Heidelberg. https://doi.org/10.1007/978-90-481-9498-8</mixed-citation></ref><ref id="scirp.114597-ref226"><label>226</label><mixed-citation publication-type="book" xlink:type="simple">Parmar, G., Rurak, E., Elderfield, M., et al. (2020) Ch. 13. 8-Year Observational Study on Naturopathic Treatment with Modulated Electro-Hyperthermia (mEHT): A Single-Centre Experience. In: Szasz, A., Ed., Challenges and Solutions of Oncological Hyperthermia, Cambridge Scholars Publishing, Newcastle upon Tyne District, 227-266.</mixed-citation></ref><ref id="scirp.114597-ref227"><label>227</label><mixed-citation publication-type="other" xlink:type="simple">Hager, E.D., Sahinbas, H., Groenemeyer, D.H., et al. (2008) Prospectivephase II Trial for Recurrent High-Grade Malignant Gliomas with Capacitive Coupled Low Radiofrequency (LRF) Deep Hyperthermia. ASCO, Journal of Clinical Oncology, Annual Meeting Proceedings (Post-Meeting Edition), 26, 2047. https://doi.org/10.1200/jco.2008.26.15_suppl.2047</mixed-citation></ref><ref id="scirp.114597-ref228"><label>228</label><mixed-citation publication-type="other" xlink:type="simple">Renner, H. and Albrecht, I. (2007) Analyseder überlebenszeiten von Patineten mit Pankreastumoren mit erfolgterkapazitativer Hyperthermiebehandlung, (Erstellt: Mr. Mirko Friedrich; May &amp; STM.</mixed-citation></ref><ref id="scirp.114597-ref229"><label>229</label><mixed-citation publication-type="other" xlink:type="simple">Dani, A., Varkonyi, A., Magyar, T. and Szasz, A. (2008) Clinical Study for Advanced Pancreas Cancer Treated by Oncothermia. Forum Hyperthermie, 1, 13-20.</mixed-citation></ref><ref id="scirp.114597-ref230"><label>230</label><mixed-citation publication-type="other" xlink:type="simple">Parmar, G. (2018) Naturopathic Anti-Tumoral Treatment &amp; 8 Year Survival Benefit Statistics: A Single-Centre Experience. 36th Conference of the International Clinical Hyperthermia Society, Budapest, 28-29 September 2018.</mixed-citation></ref><ref id="scirp.114597-ref231"><label>231</label><mixed-citation publication-type="other" xlink:type="simple">SEER (Surveillance, Epidemiology, and End Result Program) Database. https://seer.cancer.gov/data</mixed-citation></ref><ref id="scirp.114597-ref232"><label>232</label><mixed-citation publication-type="other" xlink:type="simple">Szasz, O. and Szasz, A. (2020) Parametrization of Survival Measures, Part I: Consequences of Self-Organizing. International Journal of Clinical Medicine, 11, 316-347. https://doi.org/10.4236/ijcm.2020.115031</mixed-citation></ref><ref id="scirp.114597-ref233"><label>233</label><mixed-citation publication-type="book" xlink:type="simple">Szasz, O., Szasz, A.M., Szigeti, G.P. and Szasz, A. (2020) Chapter 2. Data Mining and Evaluation of Single Arm Clinical Studies. In: Yong, X., Ed., Recent Developments in Engineering Research, Vol. 3, GAN Publishing, London, 15-74.</mixed-citation></ref><ref id="scirp.114597-ref234"><label>234</label><mixed-citation publication-type="other" xlink:type="simple">Szasz, A., Szigeti, G.P. and Szasz, A.M. (2020) Parametrization of Survival Measures, Part II: Single Arm Studies. International Journal of Clinical Medicine, 11, 348-373. https://doi.org/10.4236/ijcm.2020.115032</mixed-citation></ref><ref id="scirp.114597-ref235"><label>235</label><mixed-citation publication-type="other" xlink:type="simple">Szasz, A., Szigeti, G.P. and Szasz, A.M. (2020) Parametrization of Survival Measures, Part III: Clinical Evidences in Single Arm Studies with Endpoint of Overall Survival. International Journal of Clinical Medicine, 11, 389-419. https://doi.org/10.4236/ijcm.2020.116034</mixed-citation></ref></ref-list></back></article>